Introduction {#s1}
============

Dorsal closure (DC) in the *Drosophila* embryo is an established model for epithelial morphogenesis. The power of *Drosophila* genetics and cell biological tools have contributed to understand how signalling pathways, cell polarity and cell adhesion regulate the coordinated movements of two epithelial sheets, the epidermis and the amnioserosa (AS), a transient extraembryonic tissue \[reviewed in ([@bib135])\]. More recently, elaborate biophysical techniques combined with high resolution imaging have elucidated how contractile forces are coordinated between cells in order to drive coherent changes in tissue morphology ([@bib145]; [@bib66]; [@bib33]; [@bib167]; [@bib30]; [@bib136]). DC is a complex morphogenetic process taking about 2 hr, during which the epidermis expands dorsally to encompass the embryo. The process can be subdivided into three phases: i) elongation of the dorsal-most epidermal cells (DME) along the dorso-ventral axis; ii) contraction of AS cells and migration of the lateral epidermal cells towards the dorsal midline; iii) "zippering", i.e. adhesion of the epidermal cells from both sides on the dorsal midline \[reviewed in ([@bib43])\]. Several forces contribute to these processes. First, pulsed contraction of AS cells produces a pulling force. These pulsed contractions are correlated with dynamic apical actomyosin foci, which transiently form in the apical medial cytocortex ([@bib70]; [@bib62]; [@bib146]; [@bib42]; [@bib11]; [@bib51]). Cells delaminating from the AS contribute additional pulling forces ([@bib108]; [@bib145]; [@bib158]). Second, a supracellular actomyosin cable, formed in the DME cells, surrounds the opening and provides contractile forces ([@bib62]; [@bib131]). Finally, "zippering" of the two lateral epithelial sheets occurs, mediated by dynamic filopodia and lamellipodia ([@bib30]; [@bib64]).

A plethora of proteins contribute to coordinate this highly dynamic morphogenetic process. Beside transcription factors, these include adhesion molecules and signalling pathways, a variety of cytoskeletal proteins and their regulators. Non-muscle myosin-II heavy chain (MHC) and the non-muscle myosin regulatory light chain (MRLC), encoded by *zipper (zip*) and *spaghetti-squash (sqh*), respectively, are, together with the essential light chain, part of a force-producing molecular motor during DC \[reviewed in ([@bib163]; [@bib89])\]. The small G-proteins of the Rho family, namely Rho1, Rac1, Rac2, Mtl, and Cdc42, regulate actomyosin activity and cell-cell adhesion ([@bib2]; [@bib95]; 2002). These GTPases stimulate myosin contraction through Rho-kinase (Rok) ([@bib105]; [@bib47]) or p21-activated kinase (*D*Pak) ([@bib46]; [@bib23]; [@bib53]). They also modulate the Arp2/3 complex, which consists of seven subunits conserved in almost all eukaryotes ([@bib134]; [@bib160]). The Arp2/3 complex promotes the formation of densely branched, rapidly treadmilling actin filament arrays that, together with the Wiskott-Aldrich syndrome protein (WASP) and the WASP-family verprolin-homologous protein (WAVE), coordinate membrane-cytoskeleton dynamics ([@bib82]; [@bib77]; [@bib12]). The Arp2/3 complex also regulates endocytosis of *D*E-cadherin ([@bib39]; [@bib84]) and thus contributes to the regulation of the *zonula adherens* (ZA), an adhesion belt encircling the apex of epithelial cells ([@bib156]; [@bib102]; [@bib137]). Moreover, the *Drosophila* WAVE homolog SCAR, the main activator of Arp2/3 in fly embryos ([@bib177]), is a downstream effector of Rac, Cdc42 and *D*Pak ([@bib82]; [@bib77]). *D*Pak, in turn, can also activate the Arp2/3 complex independently of SCAR ([@bib82]; [@bib77]; [@bib177]). Thus, the regulation of cell-cell adhesion and cytoskeleton activity is closely linked to each other.

During epithelial morphogenesis, mechanisms controlling cell polarity have to be set in place to ensure tissue integrity. One of the key regulators of epithelial cell polarity in the *Drosophila* embryo is the Crumbs protein complex. Its core components are the type I transmembrane protein Crumbs (Crb) and the scaffolding proteins Stardust (Sdt), *D*Lin-7 and *D*PATJ, which are conserved from flies to mammals \[reviewed in ([@bib18]; [@bib157])\]. *Drosophila* embryos mutant for *crb* or *sdt* are unable to maintain apico-basal polarity in most of their epithelia ([@bib153]; [@bib154]; [@bib6]; [@bib56]). This leads to a complete breakdown of tissue integrity due to failure in positioning and maintaining the ZA, followed by apoptosis in many tissues, e.g. the epidermis and the AS ([@bib44]; [@bib153]; [@bib154]; [@bib156]). Comparable defects in epithelial integrity are observed in mice lacking Crb2 or Crb3 ([@bib168]; [@bib173]; [@bib149]). Conversely, over-expression of *Drosophila* Crb can lead to an expansion of the apical membrane domain, both in embryonic epithelial cells ([@bib171]) and in photoreceptor cells ([@bib109]; [@bib115]; [@bib125]). These results define Crb as an important apical determinant of epithelial cells. Besides a role in epithelial cell polarity, *Drosophila crb* controls tissue size in imaginal discs by acting upstream of the Hippo pathway \[reviewed in ([@bib15]; [@bib37])\], regulates morphogenesis of photoreceptor cells and prevents light-dependent retinal degeneration \[reviewed in ([@bib8]; [@bib18])\].

Crb contains in its extracellular domain an array of epidermal growth factor-like repeats, interspersed by four laminin A globular domain-like repeats. Its small cytoplasmic portion of only 37 amino acids contains two highly conserved motifs, a C-terminal PDZ (**P**ostsynaptic density/**D**iscs large/**Z**O-1) domain-binding motif (PBM), -ERLI, which can bind the PDZ-domain of Sdt and *D*Par-6 ([@bib86]; [@bib132]; [@bib17]; [@bib6]; [@bib56]; [@bib69]; [@bib63]), and a FERM (protein **4**.1/**e**zrin/**r**adixin/**m**oesin) domain-binding motif (FBM) ([@bib71]), which can directly interact with the FERM-domain of Yurt (Yrt), Expanded (Ex) and Moesin (Moe) ([@bib81]; [@bib88]; [@bib166]). Our previous structure-function analysis of Crb using a fosmid-based approach revealed that the PBM is essential for the maintenance of cell polarity in embryonic epithelia ([@bib72]). In contrast, the FBM is non-essential for normal development of most embryonic epithelia. At later stages of development, however, embryos with a mutation in the FBM fail to undergo DC ([@bib72]). This phenotype now provides access to unravel additional functions of this highly conserved polarity regulator. Using live imaging and genetic analysis we elucidate a novel function of Crb as a key negative regulator of actomyosin dynamics during DC. Our results also further our understanding on the mechanisms that couple the regulation of the cytoskeleton and cell-cell adhesion with the control of embryonic morphogenesis.

Results {#s2}
=======

The FBM of Crb is essential for dorsal closure {#s2-1}
----------------------------------------------

We previously showed ([@bib72]) that a fosmid covering the entire *crb* locus, named *foscrb*, completely rescues the lethality caused by the lack of endogenous *crb*. We also showed that a variant, in which the conserved tyrosine~10~ in the FERM-domain binding motif (FBM) is replaced by an alanine (*foscrb~Y10A~* variant) does not rescue embryonic lethality. Interestingly, the fosCrb~Y10A~ variant properly localises at the apical domain in most embryonic epithelia, which undergo normal morphogenesis (i.e. germ band elongation, salivary gland invagination). But later in development, germ band (GB) retraction, dorsal closure (DC) and head involution fail to occur properly ([@bib72]). This indicated that the FBM of Crb fulfils a tissue- and stage-specific morphogenetic function in the embryo. Moreover, these defects appear to be independent of a putative Tyr phosphorylation, because another variant, in which the Y10 is replaced by a phenylalanine (*foscrb~Y10F~*), completely rescues the embryonic lethality of *crb* mutants ([@bib72]). To get a better understanding of the mechanisms by which Crb regulates these morphogenetic processes, we performed detailed in vivo analyses of embryos expressing the different fosmid variants together with a *DE-cad::GFP* or a *DE-cad::mTomato* knock-in allele ([@bib60]) in a *crb* null background (*crb^GX24^* or *crb^11A22^*) (for simplicity, these are called *foscrb, foscrb~Y10A~* and *foscrb~Y10F~* from now on).

Because staging of embryos depends on morphological criteria, and *foscrb~Y10A~* mutant embryos show morphological defects, we imaged control and mutant embryos always in parallel, and stages were classified according to elapsed time after egg collection, i.e., after equal developmental times (see Materials and methods for details about staging and imaging). By the time *foscrb* embryos finish GB retraction ([Figure 1A](#fig1){ref-type="fig"}, [Video 1](#media1){ref-type="other"}), *foscrb~Y10A~* embryos ([Figure 1B](#fig1){ref-type="fig"}, [Video 2](#media2){ref-type="other"}) exhibit major defects in GB retraction, as revealed by a highly disorganised amnioserosa (AS) in which individual AS cells could hardly be followed. While *foscrb* embryos proceed through DC ([Figure 1C,E](#fig1){ref-type="fig"}, [Video 1](#media1){ref-type="other"}), those expressing the *foscrb~Y10A~* variant progressively lose the AS ([Figure 1D,F](#fig1){ref-type="fig"}) and ultimately fail to complete DC ([Video 2](#media2){ref-type="other"}). Embryos expressing the *foscrb~Y10F~* variant complete DC similar as *foscrb* embryos ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), indicating that the Y10A mutation specifically affects the progress of DC.10.7554/eLife.07398.003Figure 1.The FERM-binding domain motif (FBM) of Crb is essential for dorsal closure (DC).(**A-F**) Stills from dorsal views of live imaging of embryos expressing *D*E-cad::GFP. In all images the anterior part is towards the left. **A**, **C** and **E**, *w;foscrb,DE-cad::GFP;crb^GX24^* ([Video 1](#media1){ref-type="other"}). **B**, **D** and **F**, *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^* ([Video 2](#media2){ref-type="other"}). All embryos were collected at the same time (1 hr collection), incubated at 28ºC for 7 hr and imaged together. Numbers in (**B**,**D and F**) indicate the time in minutes for the corresponding row. While DC is completed in *foscrb* embryos (**E**), in *foscrb~Y10A~* embryos, the amnioserosa (AS) is disorganised and progressively lost (**F**). Scale bar: 100 μm. (**G-J'**) Localisation of phosphotyrosine (PY), Crb and *D*Patj in the dorsal epidermis at the beginning of DC. In all images the AS is at the top (see reference axis in **G** and in the scheme K). (**G**, **I**,**I'**) *w;foscrb;crb^GX24^*. (**H**, **J**,**J'**) *w;foscrb~Y10A~;crb^GX24^*. (**K**) Schematic representation of the dorsal epidermis at the beginning of DC indicating that the leading edge (LE) of the dorsal most epidermal (DME) cells is in contact with the AS. Arrows in (**G**,**H**) indicate LE of the DME (row of cells marked by brackets). The arrowheads indicate where the corresponding protein is absent from the LE (**I-J'**). The asterisks mark LE membranes positive for Crb (**J**) and *D*Patj (**J'**) in *foscrb~Y10A~* mutant. Scale bar: 10 μm. Representative images from 8--12 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.003](10.7554/eLife.07398.003)10.7554/eLife.07398.004Figure 1---figure supplement 1.DC in *foscrb~Y10F~* embryos.(**A**-**C**) Stills from dorsal views of live imaging of embryos expressing *D*E-cad::GFP in *w;foscrb~Y10F~,DE-cad::GFP;crb^GX24^*. Embryos collected and imaged as described in [Figure 1](#fig1){ref-type="fig"}. Numbers indicate the time in minutes for the corresponding row. DC proceeds as in *foscrb* embryos. Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.004](10.7554/eLife.07398.004)Video 1.Dorsal closure (DC) in a *w;foscrb,DE-cad::GFP;crb^GX24^* embryo.Note that the granules from the yolk are visible because of their strong auto-fluorescence in the green part of the spectrum. Time-lapse: 3.5 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.005](10.7554/eLife.07398.005)10.7554/eLife.07398.005Video 2.Defective germ band (GB) retraction and DC phenotype in a *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^* embryo.Time-lapse: 3.5 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.006](10.7554/eLife.07398.006)10.7554/eLife.07398.006

Various mechanisms have been documented to contribute to DC, including elongation of the dorsal most epidermal (DME) cells ([@bib127]). This elongation occurs normally in *foscrb* embryos, as revealed by phosphotyrosine (PY) staining associated with the ZA ([Figure 1G](#fig1){ref-type="fig"}). In contrast the DME cells of *foscrb~Y10A~* embryos do not elongate co-ordinately ([Figure 1H](#fig1){ref-type="fig"}). We analysed the localisation of Crb and *D*Patj at this stage. Both proteins are expressed at higher levels in the epidermis compared to the AS ([Figure 1I--J\'](#fig1){ref-type="fig"}). In *foscrb* embryos, Crb ([Figure 1I](#fig1){ref-type="fig"}) and *D*Patj ([Figure 1I\'](#fig1){ref-type="fig"}) are mostly absent from the leading edge (LE --[Figure 1I--I\'](#fig1){ref-type="fig"} arrowheads) of the DME cells. In contrast, in *foscrb~Y10A~* embryos both Crb~Y10A~ ([Figure 1J](#fig1){ref-type="fig"}, asterisks) and *D*Patj ([Figure 1J\'](#fig1){ref-type="fig"}, asterisks) are detected at the LE, particularly in those cells that remain short, while both are removed in cells that elongate properly ([Figure 1J,J\'](#fig1){ref-type="fig"}, arrowheads). Thus proper elongation of the DME cells fails in *foscrb~Y10A~* embryos.

The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable in the DME cells {#s2-2}
--------------------------------------------------------------------------------------------------------------------

Besides elongation of the DME cells, a complex actomyosin machinery is established at their LE. The DME cells extend filopodia and lamellipodia that are essential for correct 'zippering' ([@bib176]; [@bib29]; [@bib64]; [@bib30]). These filopodia, revealed by staining with an antibody against Stranded at Second \[Sas ([@bib27])\], extend dorsally in *foscrb* embryos ([Figure 2A](#fig2){ref-type="fig"} arrow). In contrast, filopodia in *foscrb~Y10A~* embryos are disorganised and often absent ([Figure 2B](#fig2){ref-type="fig"}, empty arrowhead and arrowhead, respectively). This is confirmed by live imaging of embryos expressing a Venus-tagged Sas protein ([Video 3](#media3){ref-type="other"}). Filopodia of *foscrb~Y10A~* embryos are erratic, and some even appear to move out of the plane ([Video 3](#media3){ref-type="other"}, arrow in *foscrb~Y10A~* embryo), probably because of the loss of contact with the AS.10.7554/eLife.07398.007Figure 2.The FBM of Crb is important the establishment of the supracellular actomyosin cable at the LE of the DME cells during DC.(**A**-**L**) Localisation of Stranded at second (Sas, **A**,**B**), Enabled (Ena, **C**,**D**), Actin (**E**,**F**), Zipper (Zip, **E'**,**F'**), Echinoid (Ed, **G**,**H**), phosphotyrosine (PY, **G'**,**H'**), Bazooka (Baz, **I**,**J**), and *D*E-cadherin (*D*E-cad, **K**,**L**) at the beginning of stage 14. In all images the AS is at the top half, for the genotypes *w;foscrb;crb^GX24^* and *w;foscrb~Y10A~;crb^GX24^*. Filopodia extend dorsally in *foscrb* embryos (**A**, arrow), but in *foscrb~Y10A~* embryos filopodia are absent (**B**, arrowhead) or disorganised (**B**, empty arrowhead). Ena, Actin and Zip concentrate at the LE in *foscrb* embryos (**C**,**E** and **E'**, arrows), but these proteins are almost absent from the LE in *foscrb~Y10A~* embryos (**D**,**F** and **F'**, arrowheads). Ed is absent from the LE of *foscrb* embryos (**G**, arrowhead), but the DME cells of *foscrb~Y10A~* embryos show an important decrease of the protein (**H**, magenta overlay) though the PY staining is still clearly associated with the ZA in the same cells (**H'**, magenta overlay). Similarly, Baz decreases at the LE of *foscrb* embryos (**I**, arrowhead), but in *foscrb~Y10A~* embryos, the cells that do not elongate keep Baz at the LE (**J**, arrow), while other DME cells show a reduction of Baz (**J**, and [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). *D*E-cad (mTomato signal) localises at all cell-cell contacts in *foscrb* embryos (**K**). However, in *foscrb~Y10A~*, the *D*E-cad localisation is affected in both the dorsal epidermis (**L**, solid arrowhead) and the AS (**L**, empty arrowheads). Scale bar: 10 μm. (**M**) Schematic representation of the changes in DME cells at the beginning of DC in embryos expressing either fosCrb or fosCrb~Y10F~. The elongation of the DME cells is accompanied by the removal of the Crb protein complex, Ed, Baz and the septate junction components from the LE. At the LE a supracellular actomyosin cable is established and filopodia extend dorsally and attach to the AS cells. Representative images from 8--12 different embryos for each genotype. (**N**) Schematic representation of the defects in the DME cells of embryos expressing the fosCrb~Y10A~ variant. At the beginning of DC, the DME cells do not elongate uniformly. In the cells that do not elongate, the Crb protein complex and Baz remain at the LE. Reduced *D*E-cad suggest defects in the ZA function. Ed is dramatically reduced in DME cells, probably contributing to the absence of the supracellular actomyosin cable. Also, the DME cells exhibit disorganised filopodia. Nevertheless, the septate junction components are properly removed from the LE. The Crb protein complex is apical to the ZA, but Ed and the actomyosin cable are associated with the ZA.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.007](10.7554/eLife.07398.007)10.7554/eLife.07398.008Figure 2---figure supplement 1.Localisation of Pyd, Dia and DAAM in *foscrb* and *foscrb~Y10F~* embryos.Localisation of Polychaetoid (Pyd, **A**,**B**), Phosphotyrosine (PY, **A'**,**B'**), Diaphanous (Dia, **C**,**D**), and Dishevelled Associated Activator of Morphogenesis (DAAM, **E**,**F**) in embryos at the beginning of stage 14. In all images the AS is at the top, for the genotypes *w;foscrb;crb^GX24^*, and *w;foscrb~Y10A~;crb^GX24^*. The localisation of Pyd (**A**,**B''**) is comparable between the different genotypes, despite the irregularly extended DME cells in *w;foscrb~Y10A~;crb^GX24^* embryos (**B**,**B'**,**B''**). The PY staining (**A'**,**B'**) marks the ZA. The localisation of Dia (**C**,**D**) and DAAM (**E**,**F**) is similar in the different genotypes. Scale bar: 10 μm. Representative images from 8--12 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.008](10.7554/eLife.07398.008)10.7554/eLife.07398.009Figure 2---figure supplement 2.The FBM of Crb is important for the establishment of the supracellular actomyosin cable.Stills from live imaging of embryos expressing Zip::GFP. In all images the anterior part is to the left. (**A**-**C**) *w;foscrb/Zip::GFP;crb^GX24^* and (**D**-**F**) *w;foscrb~Y10A~/Zip::GFP;crb^GX24^* embryos were followed during GB retraction. Numbers in (**D-F**) indicate the time in minutes for the corresponding row. Arrow in (**B**) marks the incipient formation of the supracellular actomyosin cable in a *foscrb* embryo. The supracellular actomyosin cable is continuous at later time points (**C**, arrow). In *foscrb~Y10A~*embryos, some segments of the DME cells concentrate Zip::GFP at the LE (**E**, arrow). At the time when GB retraction should be completed and thereafter, the actomyosin cable forms randomly at the LE (**F**, arrows), and several discontinuities are present (**F**, arrowheads). Scale bar: 100 μm. Representative images from 6--8 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.009](10.7554/eLife.07398.009)10.7554/eLife.07398.010Figure 2---figure supplement 3.Reduction of Baz in DME cells of *foscrb~Y10A~* embryos.Localisation of Bazooka (Baz, **A**,**B**), and phosphotyrosine (PY, **A'**,**B'**) at the beginning of stage 14 in *w;foscrb;crb^GX24^* and *w;foscrb~Y10A~;crb^GX24^* embryos. The black lines in **A-B'** mark the position for the plot profile (**C**,**D**) of the Baz signal (**C**,**D**, black line) and the PY signal (**C**,**D**, magenta line) in the DME cells. Maxima intensities overlap for both markers, but note that the intensity of Baz in *foscrb~Y10A~* embryos is lower than in *foscrb* embryos. The arrows indicate where Baz is preserved at the LE of those cells that do not elongate properly, while the asterisks mark the DME cells that extend normally, and have a reduction of Baz signal in the junctions. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.010](10.7554/eLife.07398.010)10.7554/eLife.07398.011Figure 2---figure supplement 4.Distribution of septate junction components in DME cells.Localisation of Coracle (Cora, **A**,**B**), *D*E-cad (**A'**,**B'**), Disc large (Dlg, **C**,**D**) and Yurt (Yrt, **E**,**F**) in embryos at the beginning of stage 14. In all images the AS is at the top, for *w;foscrb;crb^GX24^* and *w;foscrb~Y10A~;crb^GX24^* embryos. The septate junction proteins Cora (**A**,**B**), Dlg (**C**,**D**) and Yrt (**E**,**F**) are absent from the LE in all genotypes (arrowheads). Bracket in (**B**) marks bunching of dorsal epidermis observed in *foscrb~Y10A~*embryos. The *D*E-cad staining (**A'**,**B'**), is a maximal projection of the first ∼1.5 μm from the surface of the embryo, while the Cora staining is a maximal projection of the whole *Z*-stack. The merge of these projections (**A'',B''**) shows that Cora is mainly present in the epidermis. Scale bar: 10 μm. Representative images from 8--12 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.011](10.7554/eLife.07398.011)10.7554/eLife.07398.012Figure 2---figure supplement 5.Distribution of actomyosin and junctional components in DME cells of *foscrb~Y10F~* embryos.(**A**-**K**) Localisation of Sas at the filopodia (**A**, arrow). Ena (**B**), Actin (**C**), and Zip (**C'**) concentrate at the LE (arrows). Ed (**D**, and PY, **D'**), and Baz (**E**) are absent from the LE (arrowheads). *D*E-cad::mTomato (**F**) and Pyd (**G**, and PY, **G'**) localise at all cell-cell contacts. Localisation of Dia (**H**) and DAAM (**I**). The septate junction components Cora (**J**, the corresponding *D*E-cad, **J'** and the merge, **J''**), and Dlg (**K**) are absent from the LE (**J**,**K**, arrowheads). The localisation of all these proteins is similar to the one observed in *foscrb* embryos. Scale bar: 10 μm. Representative images from 8--12 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.012](10.7554/eLife.07398.012)Video 3.Filopodia movement at the leading edge (LE) of the dorsal most epidermal (DME) cells in *w;foscrb;crb^GX24^,Sas::Venus* (top) and *w;foscrb~Y10A~;crb^GX24^,Sas::Venus* (bottom) embryos.The filopodia at the DME cells were followed for 5 min and the movie loops 6 times. Note that the filopodia in the *foscrb~Y10A~* embryo move randomly and some filopodia, like the one label with the arrow (bottom embryo), appear to detach and move out of the plane. Time-lapse: 10 sec; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.013](10.7554/eLife.07398.013)10.7554/eLife.07398.013

A key regulator of the number and length of filopodia during DC is the actin-elongation promoting protein Enabled (Ena) ([@bib36]; [@bib113]; [@bib10]; [@bib55]). Ena concentrates at the LE of DME cells in *foscrb* embryos ([Figure 2C](#fig2){ref-type="fig"}, arrows). In contrast, Ena is strongly reduced at the LE of *foscrb~Y10A~* embryos ([Figure 2D](#fig2){ref-type="fig"}, arrowhead). Localisation of Ena at the LE depends on the ZA--associated protein Polychaetoid (Pyd) ([@bib22]). However, Pyd localisation at the ZA shows no major difference in *foscrb* and *foscrb~Y10A~* embryos ([Figure 2---figure supplement 1A--B\'\'\'](#fig2s1){ref-type="fig"}). The localisation of the formins Dia and DAAM, both involved in the growth of actin-based protrusions ([@bib101]; [@bib54]; [@bib90]), is also similar in *foscrb* and *foscrb~Y10A~* embryos ([Figure 2---figure supplement 1C--F](#fig2s1){ref-type="fig"}). This suggests that different regulators of Ena are affected in *foscrb~Y10A~* mutant embryos.

In addition to filopodia, forces produced by a supracellular actomyosin cable at the LE contribute to DC ([@bib35]; [@bib62]; [@bib70]; [@bib65]; [@bib176]). This supracellular cable, which contains actin ([Figure 2E](#fig2){ref-type="fig"}) and the non-muscle myosin II Zipper (Zip, [Figure 2E\'](#fig2){ref-type="fig"}), is correctly formed in *foscrb* embryos ([Figure 2E,E\'](#fig2){ref-type="fig"} arrows). However, it is virtually absent in *foscrb~Y10A~* embryos ([Figure 2F,F\'](#fig2){ref-type="fig"}, arrowheads). Live imaging experiments using a *zipper::GFP* protein trap line ([@bib19]; [@bib107]) reveal that Zip::GFP appears homogenously along the LE in *foscrb* embryos. In contrast, it randomly concentrates in some segments along the LE of *foscrb~Y10A~* embryos ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Together, these results show that the FBM of Crb is important for the generation and maintenance of actin-based protrusions and the correct organisation of the supracellular actomyosin cable at the LE.

The formation of the actomyosin cable at the LE depends on the removal of the adhesion protein Echinoid (Ed) from the LE and the AS cells ([@bib80]; [@bib87]). As expected, Ed in *foscrb* embryos is distributed as in wild type embryos ([Figure 2G](#fig2){ref-type="fig"}, arrowheads mark Ed absence at the LE). However, in *foscrb~Y10A~* embryos, Ed levels are strongly reduced in the DME cells ([Figure 2H](#fig2){ref-type="fig"}, magenta overlay), even though the DME cells are still in contact with the AS, as revealed by PY staining ([Figure 2H\'](#fig2){ref-type="fig"}). It has been suggested that the asymmetric distribution of Ed is essential to exclude the polarity protein Bazooka (Baz) away from the LE ([@bib80]; [@bib116]). We found that, in contrast to *foscrb* embryos ([Figure 2I](#fig2){ref-type="fig"}, arrowhead), *foscrb~Y10A~* embryos preserve Baz at the LE of those cells that fail to elongate ([Figure 2J](#fig2){ref-type="fig"}, arrow). In addition, there is a general reduction of Baz at the junctions of the DME cells of *foscrb~Y10A~* embryos ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Together, these results suggest that the FBM of Crb is important for Ed stability and hence Baz redistribution and amount in DME cells.

The asymmetric distribution of different proteins in the DME cells reflects the planar cell polarity of these cells, a feature that also includes the removal of septate junction (SJ) components from the LE ([@bib68]). We found that removal of Coracle (Cora), Discs Large (Dlg) and Yurt (Yrt) from the LE appears normal in the different fosmid variants ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}), suggesting that not all aspects of the planar polarisation of the DME cells are affected in embryos expressing the *foscrb~Y10A~* variant.

Ed, Baz and *D*E-cadherin (*D*E-cad) are all proteins associated with the ZA, which is essential in maintaining adhesion between the dorsal epidermis and the AS and for transmitting the forces generated during DC ([@bib41]; [@bib51]; [@bib82]). In *foscrb, D*E-cad localises at all cell-cell contacts, including the LE ([Figure 2K](#fig2){ref-type="fig"}, arrow). In *foscrb~Y10A~* embryos, however, the *D*E-cad signal is strongly reduced at the LE ([Figure 2L](#fig2){ref-type="fig"}, solid arrowhead). Moreover, disruption of *D*E-cad suggests a discontinuous adhesion belt in the AS cells of these embryos ([Figure 2L](#fig2){ref-type="fig"}, empty arrowheads). The loss of *D*E-cad from the LE in the *foscrb~Y10A~* embryos at this early stage is different from the normal redistribution of *D*E-cad that occurs at late stages during the zippering phase ([@bib41]). As expected, in *foscrb~Y10F~* embryos, all proteins mentioned above localise as in *foscrb* embryos ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}).

Taken together, these results show that the DC phenotype in *foscrb~Y10A~* embryos is accompanied by defects in the establishment of the complex actomyosin apparatus at the LE of the DME cells and by the disturbance or even loss of different components of the ZA (schematised in [Figure 2M,N](#fig2){ref-type="fig"}).

The FBM of Crb is essential for adhesion of the AS {#s2-3}
--------------------------------------------------

As described above, GB retraction is defective and the AS is strongly disorganised in *foscrb~Y10A~* embryos ([Figure 1F](#fig1){ref-type="fig"}). Because the AS is required during GB retraction ([@bib78]; [@bib93]; [@bib141]), we analysed by live imaging whether the AS is affected before GB retraction.

In *foscrb* and *foscrb~Y10A~* embryos, at the beginning of stage 11, AS cells are elongated along the antero-posterior axis ([Figure 3A,D](#fig3){ref-type="fig"}), highlighted by *D*E-cad::mTomato along the ZA ([Figure 3B,E](#fig3){ref-type="fig"}, arrows). In *foscrb~Y10A~* embryos, however, the continuity of *D*E-cad::mTomato is frequently disrupted ([Figure 3E](#fig3){ref-type="fig"}, arrowhead) and *D*E-cad::mTomato additionally appears in large intracellular clusters of unknown identity ([Figure 3E](#fig3){ref-type="fig"}, concave arrowheads), which are never observed in *foscrb* embryos. As GB retraction proceeds, fragmentation of the ZA continues in the AS of *foscrb~Y10A~* embryos and the tissue disintegrates ([Figure 3F](#fig3){ref-type="fig"} arrowheads and [Video 4](#media4){ref-type="other"}; and for a dorsal view of a different set of embryos see [Video 5](#media5){ref-type="other"}), while the dorsal aspect of *foscrb* embryos is covered by a continuous epithelial sheet ([Figure 3C](#fig3){ref-type="fig"}).10.7554/eLife.07398.014Figure 3.The FBM of Crb is important for the maintenance of the AS.(**A**-**F**) Stills from lateral views of live imaging of *D*E-cad::mTomato knock-in at the beginning of germ band (GB) retraction ([Video 4](#media4){ref-type="other"}). In all images the anterior part is towards the left, for the genotypes *w;foscrb,DE-cad::mTomato;crb^GX24^* and *w;foscrb~Y10A~,DE-cad::mTomato;crb^GX24^*. All embryos were collected at the same time (1 hr collection), incubated at 28ºC for 5 hr and imaged together. The numbers in (**D**,**F**) indicate the time in min. for the corresponding row. At stage 11 (**A**,**B**,**D**,**E**), the AS cells are elongated along the AP-axis, and *D*E-cad::mTomato localises along the ZA (**B**,**E**, arrows); in *foscrb~Y10A~* mutant, the continuity of *D*E-cad::mTomato along the ZA is lost (**E**, arrowhead) and *D*E-cad::mTomato is also found in large clusters (**E**, white concave arrowhead). At the end of GB retraction the AS covers the dorsal aspect of *foscrb* embryos (**E**), but in *foscrb~Y10A~* (**F**), GB retraction is impaired and *D*E-cad::mTomato signal is fragmented in the AS (**F**, arrowheads). Scale bar: 100 μm, except for (**B**,**E**) 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.014](10.7554/eLife.07398.014)10.7554/eLife.07398.015Figure 3---figure supplement 1.The FBM of Crb is important for the integrity of the AS.(**A**-**B'**) Scanning electron micrographs of dorsal views of embryos incubated for 8 hr at 28ºC after egg collection (1 hr collection) for the genotypes *w;foscrb;crb^GX24^* and *w;foscrb~Y10A~;crb^GX24^*. The boxed area in (**A**,**B**) is shown in (**A'**,**B'**) respectively. In *foscrb* embryos (**A'**) the AS appears as a flat continuous monolayer, while in *foscrb~Y10A~*embryos (**B'**), the AS is disorganised and some cells exhibit large filopodia (**B**,**B'**, arrow). Other cells are completely detached and may be AS cells or haemocytes (**B**,**B'**, arrowheads), and some cells have the appearance of apoptotic cells (**B'**, concave arrowhead). Scale bars: 100 μm (**A**,**B**) and 10 μm (**A'**,**B'**). Representative images from 17--37 embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.015](10.7554/eLife.07398.015)Video 4.Lateral views during germ band (GB) retraction in *w;foscrb,DE-cad::mTomato;crb^GX24^* (top) and *w;foscrb~Y10A~,DE-cad::mTomato;crb^GX24^* (bottom) embryos.Time-lapse: 10 min; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.016](10.7554/eLife.07398.016)10.7554/eLife.07398.016Video 5.Dorsal views during GB retraction and the beginning of DC in *w;foscrb,DE-cad::GFP;crb^GX24^* (top) and *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^* (bottom) embryos.Note that the yolk aggregates are clearly visible because they have an intense autofluorescence in the green part of the spectrum. Time-lapse: 10 min; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.017](10.7554/eLife.07398.017)10.7554/eLife.07398.017

The defects of the AS in *foscrb~Y10A~* embryos become very obvious in scanning electron micrographs ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). At stage 14, the AS forms a flat monolayer of epithelial cells in *foscrb* embryos ([Figure 3---figure supplement 1A,A\'](#fig3s1){ref-type="fig"}). In contrast, in *foscrb~Y10A~* embryos developed for the same period of time, the AS is completely disorganised. Large processes form, some of which extend over the caudal end of the embryos ([Figure 3---figure supplement 1B,B\'](#fig3s1){ref-type="fig"}, arrow). Some isolated cells are visible over the epidermis (whether these are detached AS cells or migrating haemocytes was not determined --[Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}, arrowhead), while others have the appearance of apoptotic cells ([Figure 3---figure supplement 1B\'](#fig3s1){ref-type="fig"}, concave arrowhead).

Together, these observations suggest that cell-cell adhesion in the AS is strongly disrupted in *foscrb~Y10A~* embryos, and define the FBM of Crb as an important regulator of cytoskeletal organisation and cell-cell adhesion of the AS.

The FBM of Crb is essential for the integrity of the AS {#s2-4}
-------------------------------------------------------

Our scanning electron microscopy analyses suggest that the AS of *foscrb~Y10A~* embryos undergo apoptosis. In order to determine whether apoptosis contributes to the disruption of the AS, we used the apoptotic reporter Apoliner, an RFP-GFP fusion protein localising at cell membranes of live cells. Caspase activation releases the GFP moiety, which is relatively unstable after cleavage, so dying cells have a stronger red appearance ([@bib7]; [@bib74]). Apoliner expression in the AS (specifically driven by the line GAL4^332.3^) of *foscrb* embryos ([Video 6](#media6){ref-type="other"}) revealed some apoptotic cells at the posterior canthus at the end of GB retraction ([Figure 4A](#fig4){ref-type="fig"}, arrow). In *foscrb~Y10A~* embryos developed for the same period of time, more apoptotic cells are visible, some of which detach ([Figure 4B](#fig4){ref-type="fig"}, arrowheads), while others remain attached to the posterior edge of the remaining AS ([Figure 4B](#fig4){ref-type="fig"}, arrow). As DC progresses in *foscrb* embryos, some apoptotic cells delaminate from the AS and are easily distinguished ([Video 6](#media6){ref-type="other"}, blinking arrows --some of these cells could be hemocytes with engulfed apoptotic debris, as reported previously \[[@bib7]\]). At this stage, almost all AS cells in *foscrb~Y10A~* embryos are apoptotic ([Video 6](#media6){ref-type="other"}, compare embryos at 210 min). Finally, at the end of DC, the internalised AS cells are localised in a central rod-like structure in *foscrb* embryos and subsequently die by apoptosis ([Figure 4C](#fig4){ref-type="fig"}) \[as has been reported for wild type embryos ([@bib123]; [@bib142])\], while in *foscrb~Y10A~* embryos at this time point the remaining AS cells are completely disaggregated ([Figure 4D](#fig4){ref-type="fig"}). To summarise, the AS in *foscrb~Y10A~* embryos breaks apart and undergoes premature apoptosis ([Video 6](#media6){ref-type="other"}), supporting the conclusion that an intact FBM is required for maintaining the integrity of the AS.Video 6.Dorsal views during DC in *w;foscrb,GAL4^332.3^/foscrb,UAS-Apoliner;crb^GX24^* (first row), and two examples of *w;foscrb~Y10A~,GAL4^332.3^/foscrb~Y10A~,UAS-Apoliner;crb^GX24^* (second and third rows) embryos.Apoliner GFP signal is on the left (green), the RFP signal on the middle (magenta), and the merge on the right. At the time 210 min, the blinking arrows in the merge of the *foscrb* embryo indicate some apoptotic AS cells separated clearly. Time-lapse: 10 min; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.018](10.7554/eLife.07398.018)10.7554/eLife.07398.01810.7554/eLife.07398.019Figure 4.AS detachment in *foscrb~Y10A~* embryos is accompanied by premature apoptosis.(**A**-**D**) Stills from dorsal views of live imaging of embryos in which the apoptotic reporter Apoliner is driven in the AS with the line GAL4^332.3^ ([Video 6](#media6){ref-type="other"}). Apoptotic cells in magenta appear more intense than their neighbours. In all images the anterior part is towards the left for the genotypes *w;foscrb,GAL4^332.3^/foscrb,UAS-Apoliner;crb^GX24^*, and *w;foscrb~Y10A~,GAL4^332.3^/foscrb~Y10A~,UAS-Apoliner;crb^GX24^*. All embryos were collected at the same time (1 hr collection), incubated at 28ºC for 7 hr and imaged together. The numbers in (**B**,**D**) indicate the time in minutes for the corresponding row. After GB retraction in *foscrb* embryos (**A**), some apoptotic cells are found mainly at the posterior canthus (**A**, arrow). In comparison, in *foscrb~Y10A~* embryos, some of the cells that have detached from the AS (**B**, arrowheads), as well as those in the posterior edge of the AS (**B**, arrow), are apoptotic. As DC is completed in *foscrb* embryos (**C**), a significant portion of the internalised AS cells are apoptotic, while the remaining internalised cells are still localised in a rod-like structure along the dorsal part of the embryo. In contrast, in *foscrb~Y10A~* embryos (**D**) all the remaining AS cells are apoptotic cells (the GFP signal in (**D**) does not belong to the AS). Scale bar: 100 μm. Representative images from 8--12 different embryos for each genotype. (**E**-**K**) Activation of the JNK pathway in the DME cells analysed with the enhancer trap *puc^E69^* (β--galactosidase staining). *D*E-cad staining is in green. In all images anterior is to the left for the genotypes *w;foscrb/+;crb^GX24^/puc^E69^,crb^GX24^* and *w;foscrb~Y10A~/+;crb^GX24^/puc^E69^,crb^GX24^*. From the beginning to the end of DC, Puc expression is normally induced on each side of the embryo in the single row of DME cells in both genotypes, and few positive β--gal nuclei appear below the row of DME cells (**E,F**, arrowheads). In *foscrb~Y10A~* embryos at middle DC some β--gal positive cells appear below the DME cells (**H**, arrowheads). When DC is completed in *foscrb* embryos (**I**), a single row of cells on each side of the embryo is β--gal positive, even in *foscrb~Y10A~* embryos, independently of whether the epidermis contacted the corresponding segment of the epidermis on the dorsal midline (**J**, dashed line), bunched on the same side of the embryo (J, dotted line) or fail to touch the complementing segment (**J**, arrow). Scale bar: 10 μm. (**K**) No significant difference in the number of β--gal positive nuclei at middle DC along 50 μm at the dorsal epidermis (indicated by the brackets in **G**,**H**), mean ± SD, n= 17 embryos per genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.019](10.7554/eLife.07398.019)10.7554/eLife.07398.020Figure 4---figure supplement 1.Hindsight expression in *foscrb* and *foscrb~Y10A~* embryos.(**A**-**D**) Expression of Hindsight (Hnt) at stage 12 (**A**,**C**, lateral view) and stage 14 (**B**,**D**, dorsal view). In all images the AS is inside the green dotted line. Note that the AS is properly specified in *foscrb* and *foscrb~Y10A~* embryos, and at stage 14, Hnt staining is comparable between the two genotypes (**B**,**D**), and Hnt is present even in the cells that have detached from the AS in the *foscrb~Y10A~* embryos (**D**, arrowhead). Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.020](10.7554/eLife.07398.020)10.7554/eLife.07398.021Figure 4---figure supplement 2.Localisation of integrin β~PS~ in the AS of *foscrb* and *foscrb~Y10A~* embryos.(**A**,**B**) The localisation of the integrin-β~PS~ is similar in *foscrb* and *foscrb~Y10A~*embryos. The images are projections of ∼1 μm thickness; thus, in some cells it is possible to see the localisation of the integrin-β~PS~ at the basal membrane (arrows), while in other cells it is possible to see the protein localisation at the lateral membrane (arrowheads). The inserts are magnification of a single confocal plane (0.45 μm) through the middle part of the AS cells in the respective genotypes. Scale bars: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.021](10.7554/eLife.07398.021)10.7554/eLife.07398.022Figure 4---figure supplement 3.Localisation of *D*Patj and Yrt in the dorsal epidermis.(**A**-**C''**) Cross section (*ZX* view --see reference axis in [Figure 1K](#fig1){ref-type="fig"}) of the dorsal epidermis of embryos at stage 14 stained for *D*Patj (green) and Yrt (fire LUT-pseudocolor). In all images the apical aspect of the cells is at the top and the dotted line marks the basal aspect. (**A-A''**) *w;foscrb;crb^GX24^*. (**B-B''**) *w;foscrb~Y10F~;crb^GX24^*. (**C-C''**) *w;foscrb~Y10A~;crb^GX24^*. Note that Yrt is concentrated toward the apical aspect of the cells in all genotypes. Scale bar: 5 μm. Representative images from 8--12 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.022](10.7554/eLife.07398.022)10.7554/eLife.07398.023Figure 4---figure supplement 4.JNK signalling is normal in *foscrb~Y10F~* embryos.(**A**-**C**) Activation of the JNK pathway in the DME cells analysed with the enhancer trap *puc^E69^* (β--galactosidase staining). *D*E-cad staining is in green. In all images anterior is to the left. From the beginning to the end of DC, Puc expression is normally induced on each side of the embryo in the single row of DME cells. When DC is completed, a single row of cells on each side of the embryo is β--gal positive (**C**). Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.023](10.7554/eLife.07398.023)

Several other processes are required for proper DC and integrity of the AS. At early stages, specification of the AS requires the U-shaped-group of genes (*hindsight* --*hnt, tail-up* --*tup, u-shaped* --*ush*, and *serpent* --*srp*), mutations in which produce phenotypes similar to those observed in *foscrb~Y10A~* embryos ([@bib34]; [@bib78]; [@bib175]; [@bib141]; [@bib93]). Hnt shows a strong and comparable expression pattern in the AS of *foscrb* and *foscrb~Y10A~* embryos at early and late stages ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), even in the detached AS cells of *foscrb~Y10A~* embryos ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}, arrowhead). This indicates that fate specification is not affected in *foscrb~Y10A~* embryos.

AS integrity also requires integrin-mediated attachment to the yolk sac membrane ([@bib123]). Therefore, we analysed the localisation of integrin-β~PS~, and found no major differences between *foscrb* and *foscrb~Y10A~* embryos ([Figure 4---figure supplement 2A,B](#fig4s2){ref-type="fig"}).

Yrt function is also important during DC, and zygotic *yrt* mutants have DC defects ([@bib57]), similar to the ones observed upon Crb over-expression in the AS ([@bib48]; [@bib171]). Because Yrt is a FERM protein that negatively regulates Crb by directly interacting with its FBM ([@bib81]), Yrt appeared as a likely candidate in mediating the *foscrb~Y10A~* mutant phenotype. Yrt localises at the lateral domain and concentrates towards the apical aspect in a Crb-dependent manner from stage 13 onwards ([@bib81]). We found that independently of the fosmid genotype, Yrt concentrates correctly towards the apical aspect of the cells ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Moreover, embryos expressing *foscrb* and lacking zygotic *yrt* show defects in DC mainly after GB retraction, when a failure in the zippering at the posterior canthus is patent ([Video 7](#media7){ref-type="other"}, arrow in the upper embryo). Despite this, the overall AS integrity is preserved during DC and most of the zippering is completed, leaving a hole only at the posterior canthus. This phenotype is completely different from the phenotype of *foscrb~Y10A~* embryos described above ([Video 2](#media2){ref-type="other"}). Significantly, embryos with both the zygotic *yrt* mutant allele and the *foscrb~Y10A~* variant do not show amelioration of the *foscrb~Y10A~* phenotype ([Video 7](#media7){ref-type="other"}, bottom embryo). These embryos show strong defects in GB retraction, and the integrity of the AS is lost as development progresses. These results show that the DC phenotype of *foscrb~Y10A~* embryos starts earlier in development and is more complex than that in *yrt* mutants, as the former fail in germ band retraction, lose the AS and do not progress on the zippering process. Thus, Yrt seems not to be involved in the phenotype of *foscrb~Y10A~* embryos.Video 7.DC in *yrt^∆75a^* zygotic mutants expressing the different fosmids. *w;foscrb,DE-cad::GFP;yrt^∆75a^crb^11A22^* (top) and *w;foscrb~Y10A~,DE-cad::GFP;yrt^∆75a^crb^11A22^* (bottom) embryos.The arrow in the top embryo marks the characteristic defects in the posterior canthus observed during DC in *yrt^∆75a^* zygotic mutants. In the *w;foscrb~Y10A~,DE-cad::GFP;yrt^∆75a^crb^11A22^* embryo the GB retraction and the DC phenotypes are comparable to the ones in the *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^* ([Video 2](#media2){ref-type="other"}). Time-lapse: 6 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.024](10.7554/eLife.07398.024)10.7554/eLife.07398.024

The AS regulates aspects of DME differentiation ([@bib148]) and embryos carrying mutations in components of the JNK signalling pathway show defective elongation of DME cells and fail to establish the supracellular actomyosin cable at the LE ([@bib127]; [@bib98]; [@bib126]; [@bib40]; [@bib58]; [@bib73]; [@bib122]; [@bib135]). The mutant phenotype described here is characterised by defects in both the AS and the DME cells. To assess whether defects in the DME observed in *foscrb~Y10A~* embryos are the result of impaired JNK signalling, we used the reporter line *puc-lacZ* ([@bib98]; [@bib128]). At the beginning of DC, the DME cells of *foscrb* and *foscrb~Y10A~* embryos are β-gal positive ([Figure 4E,F](#fig4){ref-type="fig"}), with few *lacZ*-positive nuclei in the row of cells ventral to DME cells ([Figure 4E,F](#fig4){ref-type="fig"}, arrowheads). At advanced DC, *foscrb* embryos still show a single row of β-gal positive cells ([Figure 4G](#fig4){ref-type="fig"}), while in *foscrb~Y10A~* embryos β-gal positive nuclei can also be found at positions more ventral to the DME cells ([Figure 4H](#fig4){ref-type="fig"}, arrowheads). However, given that there is no significant difference in the number of β-gal positive nuclei along 50 μm of the dorsal epidermis between these genotypes ([Figure 4G,H](#fig4){ref-type="fig"}, brackets and 4K), we suggest that this phenotype is the result of aberrant elongation of the DME cells in *foscrb~Y10A~* embryos (see for example [Figure 1H](#fig1){ref-type="fig"}). Accordingly, at the time when *foscrb* embryos complete DC, these embryos ([Figure 4I](#fig4){ref-type="fig"}) and *foscrb~Y10A~* embryos exhibit a single row of β-gal positive cells on each side of the dorsal epidermis ([Figure 4J](#fig4){ref-type="fig"}). This is independent of whether the epidermis fuses on the dorsal midline ([Figure 4J](#fig4){ref-type="fig"}, encircled by dashed line), closes on the same side of the epidermis, thus causing bunching of the tissue ([Figure 4J](#fig4){ref-type="fig"}, encircled by dotted line) or does not touch any contra-lateral epidermis ([Figure 4J](#fig4){ref-type="fig"}, arrow). A normal activation of JNK signalling is also observed in *foscrb~Y10F~* embryos ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}), showing that JNK signalling appears to be normal in the DME cells of *foscrb~Y10A~* embryos.

Taken together, these results support the conclusion that the FBM of Crb is an important regulator of the integrity and morphogenesis of the AS without affecting its specification during development.

The FBM of Crb controls actomyosin dynamics in the AS {#s2-5}
-----------------------------------------------------

It has been previously shown that perturbing actomyosin dynamics of the AS cells interferes with normal DC ([@bib146]; [@bib42]; [@bib33]). These dynamics, which are evident in stage 13 *foscrb* embryos ([Video 8](#media8){ref-type="other"}) similar as in wild-type embryos, is characterised by pulsed contractions of the AS cells. In *foscrb~Y10A~* embryos, however, the pulsed contraction are difficult to follow, since individual cells can hardly be distinguished due to the highly disrupted ZA ([Video 8](#media8){ref-type="other"}, compare [Figure 5A and 5B](#fig5){ref-type="fig"}). Pulsed-contraction of wild-type AS cells has been correlated with a regular appearance and disappearance of medial actomyosin foci ([@bib11]; [@bib25]; [@bib146]). These actomyosin foci are observed in *foscrb* embryos as revealed by Zip::GFP ([Video 9](#media9){ref-type="other"} and [Figure 5C](#fig5){ref-type="fig"}). Kymographs show that these foci are transient and disassemble after contraction ([Figure 5C',D'](#fig5){ref-type="fig"}). In contrast, the AS of *foscrb~Y10A~* embryos shows more Zip::GFP foci ([Figure 5D](#fig5){ref-type="fig"}), some of which are more prominent ([Figure 5D'](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Video 10](#media10){ref-type="other"}). A similar behaviour was observed for F-actin (labelled with Utrophin::GFP ([@bib121]) -data not shown). Importantly, analysis of the periodicity of foci formation shows that *foscrb* and *foscrb~Y10F~* embryos have similar pulsed contractions, while *foscrb~Y10A~* embryos have aberrant contractions, in that foci are more persistent ([Figure 5E](#fig5){ref-type="fig"}). These observations support the hypothesis that the AS of embryos expressing the Crb~Y10A~ variant is under both constant and uncoordinated contraction.Video 8.Dorsal views during the pulsed contractions of AS cells in *w;foscrb,DE-cad::GFP;crb^GX24^* (left) and *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^* (right).Time-lapse: 10 sec; 15 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.025](10.7554/eLife.07398.025)10.7554/eLife.07398.02510.7554/eLife.07398.026Figure 5.The FBM of Crb is essential for the regulation of actomyosin activity in the AS.Stills from views of the AS in live imaging of embryos expressing *D*E-cad::GFP knock-in (**A**,**B**, [Video 8](#media8){ref-type="other"}) or Zip::GFP (**C**-**D'**, [Video 9](#media9){ref-type="other"}). In all images the anterior part is towards the left. Scale bar: 10 μm. (**A**) *w;foscrb,DE-cad::GFP;crb^GX24^*. (**B**) *w;foscrb~Y10A~,DE-cad::GFP;crb^GX24^*. (**C**) *w;foscrb/Zip::GFP;crb^GX24^*. (**D**) *w;foscrb~Y10A~/Zip::GFP;crb^GX24^*. The embryos were collected during 30 min, incubated at 28ºC for 7 hr and imaged under the same conditions. The numbers in (**C**,**D**) indicate the time in seconds for the corresponding frame in [Video 9](#media9){ref-type="other"}. In *foscrb* embryos (**A**), *D*E-cad::GFP is localised at cell-cell junctions; but in *foscrb~Y10A~* (**B**) embryos *D*E-cad::GFP continuity is strongly disturbed. (**C'**,**D'**) Kymographs of the Zip::GFP foci in the magenta box in (**C,D**). Scale bar in (**C'**) 10 sec. (**E**) Histogram of the relative frequency of Zip::GFP foci duration during the pulsed contractions of the AS in *w;foscrb/Zip::GFP;crb^GX24^, w;foscrb~Y10F~/Zip::GFP;crb^GX24^* and *w;foscrb~Y10A~/Zip::GFP;crb^GX24^* embryos. The graph in the insert shows all data points collected, and indicates the mean ± SD. ANOVA test followed by a Dunnett's multiple-comparison test; ns-not significant difference. *n* = 150 foci collected from each of the three different embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.026](10.7554/eLife.07398.026)10.7554/eLife.07398.027Figure 5---figure supplement 1.The FBM of Crb regulates the actomyosin activity in the AS.Stills from [Video 10](#media10){ref-type="other"} where a Zip::GFP cluster forms and disappears (followed by the bracket) in an AS cell during the pulsed contraction in a *w;foscrb/Zip::GFP;crb^GX24^* embryo (**A**). In contrast, several Zip::GFP foci are present and do not disappear in the *w;foscrb~Y10A~/Zip::GFP;crb^GX24^* embryo (**B**). Scale bar: 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.027](10.7554/eLife.07398.027)Video 9.Dorsal views during the pulsed contractions of AS cells in *w;foscrb/Zip::GFP;crb^GX24^* (left) and *w;foscrb~Y10A~/Zip::GFP;crb^GX24^* (right).Time-lapse: 10 sec; 15 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.028](10.7554/eLife.07398.028)10.7554/eLife.07398.028Video 10.Magnifications of a small group of cells shown in the [Video 11](#media11){ref-type="other"} to see in more detail the medial foci accumulation of Zip::GFP during the cell contraction.These magnifications (2X from original) were created using a bicubic algorithm in Fiji. *w;foscrb/Zip::GFP;crb^GX24^* (left) and *w;foscrb~Y10A~/Zip::GFP;crb^GX24^* (right). Time-lapse: 10 sec; 15 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.029](10.7554/eLife.07398.029)10.7554/eLife.07398.029Video 11.Dorsal views during DC in embryos expressing the phosphatase Flw in the AS cells under the control of the GAL4^332.3^ driver.The signal from the *UAS-Actin::RFP* is not shown. *w;foscrb,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP* (top) and *w;foscrb~Y10A~,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP* (bottom). Time-lapse: 5 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.030](10.7554/eLife.07398.030)10.7554/eLife.07398.030

The activity of non-muscle myosin-II (Zip) is mainly regulated by the phosphorylation state of the myosin-regulatory light chain \[reviewed in ([@bib151])\], encoded by the gene *spaghetti squash (sqh*). Thus, if over-active actomyosin is responsible for the DC defects of *foscrb~Y10A~* embryos, we expect that expressing Flapwing (*flw*), the major *Drosophila* Sqh phosphatase ([@bib161]), may suppress the DC defects. In fact, UAS-driven expression of Flw in the AS of *foscrb~Y10A~* embryos leads to a suppression of the DC phenotype ([Figure 6D--F](#fig6){ref-type="fig"}, [Video 11](#media11){ref-type="other"}), while it does not produce any evident dominant phenotype in *foscrb* or *foscrb~Y10F~* embryos ([Figure 6A--C](#fig6){ref-type="fig"}, and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Interestingly, Flw over-expression also suppresses the disruption of the ZA in the AS ([Video 12](#media12){ref-type="other"}, compare B vs. D). This result supports our hypothesis that the FBM of Crb negatively regulates actomyosin activity in the AS.10.7554/eLife.07398.031Figure 6.Expression of the myosin phosphatase Flapwing in the AS of *foscrb~Y10A~* embryos suppresses the DC defects.(**A**-F) Stills from dorsal views of live imaging of embryos expressing *D*E-cad::GFP knock-in and Flw-HA in the AS cells under the control of the GAL4^332.3^ driver ([Video 11](#media11){ref-type="other"}), for the genotypes *w;foscrb,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP* and *w;foscrb~Y10A~,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*. All embryos were collected at the same time (1 hr collection), incubated at 28ºC for 7 hr and imaged together. The numbers on (**D-F**) indicate the time in minutes for the corresponding row. The over-expression of Flw-HA in the AS cells does not produce any obvious phenotype in *foscrb* (**A-C**) embryos, and it suppresses the DC defects in *foscrb~Y10A~* (**D-F**) embryos; some defects found include an irregular zippering at the posterior canthus (**E**, arrow) as well as bunching of the dorsal epidermal (**F**, bracket). Scale bar: 100 μm. Representative images from 6--9 different embryos for each genotype. (**G**) Scheme of the possible pathways regulated by the FBM of Crb in the AS. Crb: Crumbs; Rok: Rho-kinase; *D*pak: *Drosophila* p21-activated kinase; Flw: Flapwing; *D*MBS: *Drosophila* myosin-binding-subunit; Sqh: spaghetti-squash; Mlck: myosin-light chain kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.031](10.7554/eLife.07398.031)10.7554/eLife.07398.032Figure 6---figure supplement 1.Normal DC after Flapwing expression in the AS of *foscrb~Y10F~* embryos.(**A**-**C**) Stills from dorsal views of live imaging of embryos expressing *D*E-cad::GFP knock-in and Flw-HA in the AS cells under the control of the GAL4^332.3^ driver, for the genotype *w;foscrb~Y10F~,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*. Embryo collection, incubation and imaging as described in [Figure 6](#fig6){ref-type="fig"}. The numbers on (**A-C**) indicate the time in minutes for the corresponding row. The over-expression of Flw-HA in the AS cells does not produce any obvious phenotype. Scale bar: 100 μm. Representative images from 7 different embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.032](10.7554/eLife.07398.032)Video 12.Flw expression in the AS of *foscrb~Y10A~* embryos suppresses the disruption of the ZA.Dorsal views during the pulsed contractions of AS cells. The signal from the *UAS-Actin::RFP* is not shown. (**A,B**) Embryos that do not express the Flw and are trans-heterozygous for *D*E-cad::GFP; (**A**) *w;foscrb/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP* and (**B**) *w;foscrb~Y10A~/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*. (**C,D**) Embryos that express Flw in the AS cells under the control of the GAL4^332.3^ driver; (**C**) *w;foscrb,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP* and (**D**) *w;foscrb~Y10A~,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*. Time-lapse: 10 sec; 15 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.033](10.7554/eLife.07398.033)10.7554/eLife.07398.033

Rho GTPases have been shown to stimulate myosin contraction by activating Rho-kinase (Rok) or the p21-activated kinase (*D*Pak), and are required for proper DC ([@bib105]; [@bib47]; 1996; [@bib23]; [@bib95]; 2002). To test whether Rho-GTPases are involved in the Crb-mediated DC phenotype, we expressed different versions of established Rho family effectors (see working model in [Figure 6G](#fig6){ref-type="fig"}) and examined their effects on DC in the embryonic cuticle, a suitable read-out of DC. We grouped the embryos according to their cuticle phenotype into two major categories ([Figure 7A](#fig7){ref-type="fig"}): 1) embryos with "DC-defect", which exhibit a range of defects from extensive dorsal opening (in which the mouthparts are exposed), to embryos with complete DC, which, however, still failed to hatch; and 2) embryos with "WT-like" cuticle, which includes all those that hatch (for more details about the different categories and phenotypes see [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Depending on the *crb* allelic combination, 89--98% of embryos expressing the *foscrb~Y10A~* variant fall into the "DC-defect" category ([Figure 7A](#fig7){ref-type="fig"}, 1^st^-6^th^ black bars).10.7554/eLife.07398.034Figure 7.Reduction in actomyosin activity suppresses the DC defects in embryos expressing the *foscrb~Y10A~* variant.(**A**) Quantification of the defects observed in cuticle preparations from the genotypes indicated in the graph. For the complete genotype see [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. The category "DC defect" includes a range of defects ranging from cuticles of embryos that completed DC but do not hatch, to cuticles with large DC openings. The category "WT-like" includes all larvae that hatch. For details about the classifications see [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}. Note that all the genotypes have the *foscrb~Y10A~* background, except the ones highlighted in magenta, numbers 18 and 19, that have the *foscrb* background. mean ± SD from 2--4 independent crosses. n = total number of cuticles counted for the indicated genotype. Note that suppression of the DC phenotype in *foscrb~Y10A~* embryos is particularly evident upon expression of Flw-HA (10), Pak-AID (17), and *D*E-cad (22). (**B**-**F**) Adult flies of the indicated genotypes. In (**F**), the arrowhead marks the defects in the dorsal abdomen.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.034](10.7554/eLife.07398.034)10.7554/eLife.07398.035Figure 7---figure supplement 1.Reduction in the actomyosin activity suppresses the DC defects in embryos expressing the *foscrb~Y10A~* variant.Quantification of the defects observed in cuticle preparations from the genotypes indicated in the graph. In the category "Open cuticle", the dorsal opening is so prominent that in some cases the mouthparts are exposed (arrowhead). Category "Dorsal hole" corresponds to those cuticles in which a medium (left picture) or small (right picture) dorsal hole is present, but the anterior part is closed. In the category "Closed but not hatched", the closure is complete, the puckering of the epidermis is noticeable (arrowhead), but the larvae fail to hatch. In the category "Kinked larvae", the puckering of the epidermis (arrowhead) results in larvae with the tail pointing upwards, so the larvae seem to have a kink. In the category "WT-like", no defects are evident so the larvae are alike to wild type. mean ± SD from 2--4 independent crosses. n = total number of cuticles counted for the indicated genotype. For the statistical analysis see [Table 1](#tbl1){ref-type="table"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.035](10.7554/eLife.07398.035)10.7554/eLife.07398.036Figure 7---figure supplement 2.Phosphorylated *D*Moesin levels are reduced in embryos expressing the *foscrb~Y10A~* variant.Localisation of phospho-*D*Moesin (P-*D*Moe, **A**,**B**) in embryos at the beginning of stage 14. In all images the AS is at the top, for the genotypes *w;foscrb;crb^GX24^* and *w;foscrb~Y10A~;crb^GX24^*. The LE of *foscrb~Y10A~*embryo is marked with a magenta line (**B**). Scale bar: 10 μm. Representative images from 9 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.036](10.7554/eLife.07398.036)10.7554/eLife.07398.037Figure 7---figure supplement 3.Weak head phenotype of embryos expressing the *foscrb~Y10A~* variant.Examples of cuticles with a weak head phenotype: the arrows mark an opening in the anterior part.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.037](10.7554/eLife.07398.037)10.7554/eLife.07398.038Table 1.Statistical analyses of the results shown in the [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.038](10.7554/eLife.07398.038)Open cuticleDorsal holeClosed but not hatchedKinked larvaeWT-like1*foscrb~Y10A~;crb^GX24^*vs14*foscrb~Y10A~/Rho1^1B^;crb^GX24^*∗∗nsns∗∗∗∗2*foscrb~Y10A~,DE-cad::GFP;crb^GX24^*vs23*foscrb~Y10A~,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^*∗∗∗∗nsns∗∗∗∗∗∗∗∗vs25*foscrb~Y10A~,DE-cad::GFP/Arpc^1Q25st^,DE-cad::GFP;crb^GX24^*nsnsnsnsns3*foscrb~Y10A~,DE-cad::GFP/+;crb^11A22^/crb^GX24^*vs11*flw^6^/Y/w^\*^;foscrb~Y10A~,DE-cad::GFP/+;crb^11A22^/crb^GX24^*∗∗∗∗∗∗∗∗nsnsvs15*rok^2^/Y/w^\*^;foscrb~Y10A~,DE-cad::GFP/+;crb^11A22^/crb^GX24^*∗nsnsnsnsvs24*foscrb~Y10A~,DE-cad::GFP/+;crb^11A22^,Arp3^EP3640^/crb^GX24^*nsnsnsns∗∗5*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^*vs7*29ºC foscrb~Y10A~,GAL4^332.3^/UAS-Crb^full\ length^;crb^GX24^/crb^11A22^*nsnsnsnsnsvs8*25ºC foscrb~Y10A~,GAL4^332.3^/UAS-Crb^full\ length^;crb^GX24^/crb^11A23^*nsnsnsns∗∗∗∗vs9*18ºC foscrb~Y10A~,GAL4^332.3^/UAS-Crb^full\ length^;crb^GX24^/crb^11A24^*nsnsnsns∗∗∗∗vs12*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Rho^N19^*∗∗nsnsns∗∗vs13*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-rok.CAT-KG*nsnsnsns**∗**vs16*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Rac^N17^*nsnsnsnsnsvs21*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Dmoe-myc*nsnsnsnsnsvs22*foscrb~Y10A~,GAL4^332.3^/UAS-DE-cad,DE-cad::GFP;crb^GX24^/crb^11A22^*∗∗∗∗∗∗∗nsns∗∗∗∗6*foscrb~Y10A~,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*vs10*foscrb~Y10A~,GAL4^332.3^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*ns∗∗∗∗ns∗∗∗∗∗vs17*foscrb~Y10A~,GAL4^332.3^/UAS-DPak-AID,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*ns∗∗∗∗nsns∗∗∗∗vs20*foscrb~Y10A~,GAL4^332.3^/UAS-Dmoe^T559D^,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*ns∗nsns∗∗∗∗18*foscrb,GAL4^332.3^/UAS-Dpak-myr,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*vs19*foscrb,GAL4^332.3^/DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Act::RFP*∗∗∗∗∗∗∗∗∗ns∗∗∗∗[^1]

Using this read-out, we confirm that over-expression of the myosin phosphatase Flw in the AS strongly suppresses the DC defects of *foscrb~Y10A~* embryos. In fact, \>75% hatch ([Figure 7A](#fig7){ref-type="fig"}, 10^th^ vs. 6^th^ bars) and even some *foscrb~Y10A~* adults eclose with no obvious defect ([Figure 7C](#fig7){ref-type="fig"}). Interestingly, cuticles from *foscrb~Y10A~* and hemi- or homozygous for the *flw^6^* allele show an enhanced DC phenotype in comparison with the *foscrb~Y10A~* with a wild type *flw* allele ([Figure 7A](#fig7){ref-type="fig"}, 3^rd^ vs. 11^th^ black bars: 91.2% to 97.1%; and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, 3^rd^ vs. 11^th^ black bars, completely open cuticle from 27.7% to 73.5%). These results support the conclusion that the FBM of Crb regulates the AS actomyosin dynamics by regulating myosin activity.

In line with this conclusion we found that over-expression of dominant-negative Rho (Rho^N19^) or a kinase-dead Rok (Rok-CAT-KG) in the AS of *foscrb~Y10A~* increases the number of hatched larvae ([Figure 7A](#fig7){ref-type="fig"}, 5^th^ vs. 12^th^ and 13^th^ gray bars: from 2.9% to 13.4% and 10.0%, respectively), and the proportion of embryos with open cuticles is reduced ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, 5^th^ vs 12^th^ and 13^th^ black bars, from 52.7% to 23.6% and 28.5%, respectively). Moreover, *Rho1^1B^* hemizygosity effectively suppresses the DC defects of *foscrb~Y10A~* embryos ([Figure 7A](#fig7){ref-type="fig"}, 14^th^ bar vs. 1^st^ black bars, 79.2 vs. 98.3%). In contrast, *foscrb~Y10A~* embryos hemi- or homozygous for *rok^2^* show no suppression of the DC phenotypes ([Figure 7A](#fig7){ref-type="fig"}, 15^th^ vs. 3^rd^ bars), which suggests that *rok* deficiency may be deleterious in the *foscrb~Y10A~* background and that other morphological processes dependent on Rok could be affected ([@bib144]; [@bib76]; [@bib99]; [@bib9]). Similarly, over-expression of dominant-negative Rac1 (Rac1^N17^) in the AS of *foscrb~Y10A~* embryos does not suppress the DC phenotype ([Figure 7A](#fig7){ref-type="fig"}, 16^th^ vs. 5^th^ bars) and even appears to increase the proportion of embryos with open cuticles ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, 5^th^ vs. 16^th^ black bars, from 52.7% to 72.9%). We assume that the phenotypic enhancement is due to an additive effect, since over-expression of Rac1^N17^ in wild-type embryos results in DC defects ([@bib48]).

An important regulator of cytoskeleton activity downstream of Rho GTPases is *D*Pak ([@bib53]). Interestingly, over-expression of the auto-inhibitory domain of *D*Pak *\[D*Pak-AID -([@bib23])\] in the AS of *foscrb~Y10A~* embryos leads to a very strong suppression of the DC phenotype, as 59% of those embryos hatch ([Figure 7A](#fig7){ref-type="fig"}, 17^th^ vs. 6^th^ bars), and even adult flies eclose ([Figure 7D](#fig7){ref-type="fig"}). Accordingly, over-expression of constitutive active *D*Pak (*D*Pak-myr) in the AS of otherwise viable *foscrb* embryos leads to embryonic lethality with \>90% of embryos with a DC-defect ([Figure 7A](#fig7){ref-type="fig"}, 18^th^ vs. 19^th^ bars). These results indicate that unregulated activation of *D*Pak in the AS is sufficient to produce defects in DC, and that this kinase plays a major role in the defects observed in the *foscrb~Y10A~* embryos.

*D*Moe has been shown to antagonise the activity of the Rho pathway ([@bib147]; [@bib111]; [@bib52]). The participation of *D*Moe in the process under discussion here is supported by the fact that the FBM of Crb can recruit *D*Moesin (*D*Moe) to the membrane ([@bib110]) and physically interacts with it ([@bib166]), and that phosphorylated-*D*Moe (P-*D*Moe) is reduced in stage 11 *foscrb~Y10A~* embryos ([@bib72]). This reduction in P-*D*Moe persists during DC ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). In line with this, over-expression of the phosphomimetic form *D*Moe^T559D^ in the AS of *foscrb~Y10A~* embryos notably increases the number of larvae that hatch ([Figure 7A](#fig7){ref-type="fig"}, 6^th^ vs. 20^th^ gray bars, from 10.8% to 30.9%), while over-expression of *D*Moe does not ameliorate the DC defects in those embryos ([Figure 7A](#fig7){ref-type="fig"}, 21^st^ bar). This suggests that the regulation of the cytoskeleton dynamics by Crb is mediated in part by the active form of *D*Moe. Together these results let us to conclude, that the FBM of Crb regulates actomyosin dynamics in the AS during DC by down-regulating the activity of the Rho1 pathway.

We wanted to exclude the possibility that the phenotypes observed are due to a dominant effect of the Y10A mutation. In fact, over-expression of full-length Crb^WT^ in the AS of wild-type embryos leads to premature contraction of the AS and a DC phenotype ([@bib48]; [@bib171]). Driving the expression of UAS-Crb^WT^ in the AS of *foscrb~Y10A ~*embryos leads to a suppression of the DC phenotype, as \>36% hatch at 18ºC ([Figure 7A](#fig7){ref-type="fig"}, 8^th^ and 9^th^ bars vs. 5^th^ gray bars), while inducing a stronger over-expression by maintaining embryos at 29°C does not ameliorate the *foscrb~Y10A ~*phenotype ([Figure 7A](#fig7){ref-type="fig"}, 5^th^ vs. 7^th^ bars). These results show that the DC phenotype of *foscrb~Y10A~* embryos is due to loss of Crb function.

The FBM of Crb is essential for the stability of *D*E-cadherin in the AS {#s2-6}
------------------------------------------------------------------------

Besides an over-active actomyosin network, *foscrb~Y10A~* embryos exhibit interruptions in *D*E-cad distribution ([Figures 2L](#fig2){ref-type="fig"}, [3F](#fig3){ref-type="fig"} and [5B](#fig5){ref-type="fig"}). In addition some embryos show weak head-involution defects ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}), a phenotype reminiscent to that of weak alleles of *shotgun (shg*) (the gene encoding *D*E-cad) ([@bib156]), *armadillo (arm*) (the gene encoding β-catenin) ([@bib102]) or *α-Cat* ([@bib137]). Therefore we asked whether the DC phenotype of *foscrb~Y10A~* embryos could be rescued by restoring a functional adhesion belt. Over-expression of *D*E-cad in the AS of these embryos indeed can suppress the DC phenotype, as 70% of the larvae hatched ([Figure 7A](#fig7){ref-type="fig"}, 22^nd^ vs. 6^th^ bars), and even adult animals are obtained ([Figure 7E](#fig7){ref-type="fig"}).

A likely candidate of *D*E-cad regulation is the Arp2/3 complex, which has been shown to regulate endocytosis of *D*E-cad ([@bib39]; [@bib84]). In addition, reducing the activity of the Arp2/3 complex suppresses the DC phenotype of *α-Cat* mutants ([@bib137]). Therefore, we tested the effects of removing one copy of *SCAR, Arp3* or *Arpc1* on the DC phenotype of *foscrb~Y10A~* embryos. Strikingly, *foscrb~Y10A~* embryos that are heterozygous for *SCAR^∆37^* exhibit only minor defects in GB retraction ([Figure 8B](#fig8){ref-type="fig"}), partially restore *D*E-cad::GFP localisation in the AS (compare [Figure 8H](#fig8){ref-type="fig"} with [Figure 5B](#fig5){ref-type="fig"}) and completed DC ([Figure 8F](#fig8){ref-type="fig"}, [Video 13](#media13){ref-type="other"}). In fact, \~28% of these larvae hatch, as revealed by the cuticle phenotype ([Figure 7A](#fig7){ref-type="fig"}, 23^rd^ vs. 2^nd^ bar), and even some of the *w;foscrb~Y10A~,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^* develop into adult flies that exhibit defects in abdominal development ([Figure 7F](#fig7){ref-type="fig"}, arrowhead). A similar suppression was obtained in *foscrb~Y10A~* embryos heterozygous for *Arp3^EP3640^* ([Video 14](#media14){ref-type="other"}) ([Figure 7A](#fig7){ref-type="fig"}, 24^th^ vs. 3^rd^ bar). *foscrb* embryos heterozygous for *SCAR^∆37^ or Arp3^EP3640^* show normal DC ([Figure 8E](#fig8){ref-type="fig"} and [Video 14](#media14){ref-type="other"}).10.7554/eLife.07398.039Figure 8.Reduction of the SCAR-Arp complex activity suppresses the DC defects and ameliorates the loss of *D*E-cadherin in the AS of embryos expressing the *foscrb~Y10A~* variant.(**A**-**F**) Stills from dorsal views of live imaging of embryos expressing *D*E-cad::GFP knock-in and heterozygous for the *SCAR^∆37^* loss of function allele ([Video 13](#media13){ref-type="other"}). In all images the anterior is to the left, for the genotypes *w;foscrb,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^* and *w;foscrb~Y10A~,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^*. All embryos were collected at the same time (1 hr collection), incubated at 28ºC for 7 hr and imaged together. The numbers in (**B**,**D**,**F**) indicate the time in minutes for the corresponding row. DC occurs normally in *foscrb* (**A**,**C**,**D**) embryos heterozygous for the *SCAR^∆37^* allele, and DC defects are suppressed in *foscrb~Y10A~* (**B**,**D**,**F**) embryos; some defects still visible include the impaired GB retraction (compare **B** with **A**), asymmetric position of the posterior spiracles (**D**, arrows), and bunching of the dorsal epidermis (**D**, bracket). Scale bar: 100 μm. (**G**,**H**) Magnified views of AS from (**A**,**B**, respectively). Note that, in order to make the localisation of *D*E-cad::GFP more perceptible, the autofluorescence of the yolk (visible in **A**,**B**) was removed from the original stack by hand using Fiji. Scale bar: 100 μm. Representative images from 6--9 different embryos for each genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.039](10.7554/eLife.07398.039)Video 13.Dorsal views during DC in embryos heterozygous for the *SCAR^∆37^* allele.*w;foscrb,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^* (top) and *w;foscrb~Y10A~,DE-cad::GFP/SCAR^∆37^,DE-cad::GFP;crb^GX24^* (bottom). Time-lapse: 10 min; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.040](10.7554/eLife.07398.040)10.7554/eLife.07398.040Video 14.Dorsal views during DC in embryos heterozygous for the *Arp3^EP3640^* allele.*w;foscrb,DE-cad::GFP/+;crb^11A22^,Arp3^EP3640^/crb^GX24^* (top) and *w;foscrb~Y10A~,DE-cad::GFP/+;crb^11A22^,Arp3^EP3640^/crb^GX24^* (bottom). Time-lapse: 10 min; 8 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.041](10.7554/eLife.07398.041)10.7554/eLife.07398.041

In summary we could demonstrate that the DC phenotype of embryos expressing Crb~Y10A~ is due to enhanced Rho-mediated actomyosin activity and reduced adhesion. Whether these two processes are linked or independent functions downstream of Crb remains to be discussed.

Discussion {#s3}
==========

Dorsal closure is an ideal model to study how coordinated behaviour of epithelial sheets controls morphogenesis. Here we present data to show that a mutation in the FERM-domain binding motif of the polarity determinant Crb affects major steps during DC, namely elongation of the DME cells, proper formation of the actomyosin cable at the LE, and regulated constriction of the AS cells. In addition, impaired *D*E-cad localisation suggest impaired adhesion. Overall, our results define a novel role of the FBM of Crb as an essential negative regulator of actomyosin dynamics in the AS during DC in *Drosophila*. This function is not allele-specific, since embryos carrying a *crb* allele, in which Y10, P12 and E16 in the FBM are replaced by alanines ([@bib60]) develop a similar DC phenotype as *foscrb~Y10A~* embryos (data not shown). Genetic interaction studies revealed that this function of the FBM is mediated by *D*Moesin, members of the Rho family, the p21 activated kinase *D*Pak, and the SCAR-Arp2/3 complex ([Figure 6G](#fig6){ref-type="fig"}).

One phenotype observed upon complete loss of function of *crb* is a failure to maintain an intact ZA, a phenotype associated with the loss of polarity of many embryonic epithelia ([@bib153]; [@bib153]; [@bib154]; [@bib44]; [@bib156]). In fact, the AS is the tissue that is affected earliest (late stage 7/early stage 8) in *crb* mutant embryos ([@bib156]). However, *foscrb~Y10A~* embryos exhibit disrupted *D*E-cad staining in the AS only from stage 11 onward. Therefore, we suggest that the way how Crb controls maintenance of ZA integrity in the AS at later stages is different from its early function, which depends on a functional PBM ([@bib170] [@bib72]) and its interactions with the Par complex ([@bib106]; [@bib49]). However, whether Crb, and in particular its FBM, regulates ZA integrity during DC by a different mechanism, or whether defects in the ZA are a secondary consequence of impaired actomyosin activity, remains to be determined.

Several of our results are compatible with the assumption that Crb regulates actomyosin dynamics, but since *foscrb~Y10A~* mutant embryos show defects both in the AS and the DME cells, we cannot distinguish in which of the tissues Crb activity is primarily required and whether defects observed in the DME of *foscrb~Y10A~* mutant embryos are secondary consequences of excessive contraction of the AS cells. Previous results clearly show that the activity of one tissue affects the behaviour of the respective other ([@bib70]; [@bib62]; [@bib42]; [@bib146]). For example, *zip* mutants have DC and head involution defects, and restoring *zip* function in either the dorsal epidermis or the AS is sufficient to rescue dorsal-open phenotypes ([@bib35]). Similarly, expression of Pak-AID in the AS of *foscrb~Y10A~* mutants is sufficient to recover proper elongation of the DME (data not shown). However, the multitude of phenotypes observed in the DME cells of *foscrb~Y10A~* mutant embryos, such as persistence of Crb~Y10A~, *D*Patj and Baz proteins and decrease of Ed expression at the LE, as well as disruption of the supracellular actomyosin cable and disorganised filopodia, suggest that Crb performs also specific functions in the DME. One possibility is that Crb influences actomyosin activity and filopodia formation in the DME cells by regulating the stability and localisation of Ena, the major regulator of protrusive activity at the LE ([@bib113]). Another possibility is that Crb regulates the LE actomyosin by modulating the localisation of Baz. In wild-type embryos, the removal of Baz from the LE ([@bib80]) allows the relocation of the lipid phosphatase Pten, which, in turn, results in a localised accumulation of phosphatidylinositol-3,4,5-trisphosphate at the LE, promoting the formation of filopodia along the LE ([@bib116]).

Crb regulates actomyosin dynamics {#s3-1}
---------------------------------

The most prominent phenotype of *foscrb~Y10A~* embryos is the over-contraction of AS cells, most likely mediated by *D*Pak. In fact, cortical localisation of *D*Pak in the AS of *foscrb~Y10A~* embryos appears to be increased in some cells (data not shown). In addition, over-expression of Pak-AID in the AS of *foscrb~Y10A~* suppresses the GB retraction and DC phenotypes. A similar degree of suppression was observed upon over-expression of Flw, a negative regulator of Sqh. Members of the Rho GTPase family are well-established upstream regulators of actomyosin dynamics. Our data suggest that Rho1 plays a crucial role downstream of Crb, since heterozygosity of *Rho1^1B^* partially suppresses the DC phenotype of *foscrb~Y10A~* embryos. Previous data showed that over-expression of the constitutively active or dominant-negative form of Rac1 in the AS of wild-type embryos results in AS disruption ([@bib48]). Our observation that the phenotype of *foscrb~Y10A~* embryos is enhanced upon expression of a dominant negative form of Rac1 in the AS of *foscrb~Y10A~* embryos suggests that Rac1 may act upstream of Crb or in a parallel pathway. Since the effects of dominant negative Cdc42^N17^ could not be studied due to technical difficulties (see Materials and methods), we cannot exclude any contribution of Cdc42 in this process. Therefore, our data so far support a role of Rho1 in the Crb-mediated control of actomyosin dynamics in the AS ([Figure 6G](#fig6){ref-type="fig"}).

The FERM protein *D*Moe is a likely candidate to link the FBM of Crb to Rho1 activity. *Dmoe* mutant imaginal epithelial cells lose epithelial markers and intercellular adhesion, become motile and show invasive behaviour ([@bib147]). In addition, lack of *D*Moe activates the Rho1-Rok-myosin cascade and JNK-mediated apoptosis in imaginal discs ([@bib164]; [@bib111]). In fact, the FBM of Crb can recruit Moe to the cell membrane, a process that fails upon replacement of Tyr10 or Arg7 by Ala in the FBM of Crb ([@bib111]; [@bib110]). Similarly, mutating Tyr10 in the FBM of the intercellular adhesion molecule (ICAM)-2 or the equivalent Tyr residue in the FBM of the neural cell adhesion molecule L1 impairs interaction with the FERM proteins radixin and ezrin, respectively ([@bib45]; [@bib21]). Moreover, it has been shown recently that the FBM of Crb is necessary for organising *D*Moe, aPKC and the actin cytoskeleton at the marginal zone in the developing follicular epithelium ([@bib143]). And in cervical carcinoma cells, over-expression of the mammalian CRB3 protein restores an epithelial-like morphology by organising a cortical actomyosin network through the regulation of the p114RhoGEF-RhoA-ROCK1/2 pathway via the FERM protein Ehm2 ([@bib91]). Finally, recent works documented direct binding between Moesin and Crb, which was abolished upon Y10A substitution ([@bib166]).

It is unlikely that one of the other two established binding partners of the FBM of Crb, Ex and Yrt ([@bib88]; [@bib129]; [@bib81]), mediates the Crb function in the AS. So far, no role of Ex during DC has been reported, and *ex* mutant embryos reach stage 16 of development without showing major morphogenetic defects ([@bib97]). Yrt is expressed in the AS and the epidermis, but this is not affected in *foscrb~Y10A~* embryos. In addition, the DC phenotype of zygotic *yrt^∆75a^* mutants is less severe than the one observed in *foscrb~Y10A~* embryos. Finally, we do not observe increased Crb protein levels in *foscrb~Y10A~* embryos, which would be expected if the interaction between Yrt and Crb is impaired ([@bib81]).

Further support for a more direct role of Crb in regulating the actomyosin network comes from the observation that Crb co-localises with *D*Par-6, aPKC and Baz at the medial actomyosin foci in the AS ([@bib25]; [@bib26]). Given the known interactions between members of the Crb complex with members of the Par complex \[reviewed in ([@bib18]; [@bib157]; [@bib130])\], David et al. ([@bib25]) suggest that Crb in apical medial foci provides an anchor for PAR proteins. They go on to show that Baz and Par6-aPKC have opposite effects on foci duration, in that Baz promotes and Par6-aPKC complex inhibits the duration of foci. The interplay between these polarity complexes and the actomyosin system seems to establish a delayed negative feedback that promotes the cyclic contractions in the AS ([@bib25]; [@bib26]). In fact, Crb::GFP also exhibits a similar pulsation as Zip::GFP in the AS (own unpublished observations), so it will be important to analyse whether Crb~Y10A~::GFP mutant proteins have different dynamics in comparison to the wild type Crb.

Crb--a regulator of ZA integrity via actomyosin dynamics? {#s3-2}
---------------------------------------------------------

Given the observation that at early stages of embryonic development the PBM is required for ZA stability, and that the Crb~Y10A~ mutant protein has an intact PBM, it is possible that during DC, Crb-mediated regulation of actomyosin dynamics impacts on ZA stability. Interestingly, *D*Pak is not only a regulator of actomyosin dynamics, but is also involved in supporting ZA stability, both in *Drosophila* and in mammalian cells ([@bib92]; [@bib16]; [@bib4]; [@bib117]; [@bib104]; [@bib103]). The role of *D*Pak itself in DC morphogenesis is still controversial. Previous work showed that cell shape changes in the AS occur normally in embryos lacking maternal and zygotic *Dpak* and that inhibition of *D*Pak in the AS does not prevent apical constriction of amnioserosa cells ([@bib23]). However, wild-type embryos expressing Pak-AID in the AS show defects in head involution and DC, which are stronger than those of embryos devoid of maternal and zygotic *D*Pak. This led the authors to suggest that Pak-AID may also affect the activity of a second kinase, Pak3, in the AS ([@bib23]). Thus, whether inhibition of *D*Pak, Pak3 or both upon expression of Pak-AID in *foscrb~Y10A~* embryos accounts for the rescuing effect of the DC phenotype, including rescue of the ZA, remains to be clarified.

How can *D*Pak regulate ZA integrity? ZA remodelling is essential for morphogenesis, and this remodelling is driven by the endocytosis and recycling of junctional components ([@bib50]; [@bib100]). *D*Pak can activate the Arp2/3 complex directly or via the *Drosophila* WAVE homolog SCAR ([@bib82]; [@bib77]; [@bib177]). Arp2/3, in turn, has been implicated in the regulation of ZA stability, e.g. in the *Drosophila* notum, where it maintains ZA stability by regulating the endocytosis of junctional components ([@bib165]; [@bib119]; [@bib82]; [@bib39]; [@bib84]). Moreover, reducing the activity of the Arp2/3-complex suppresses the DC phenotype of *α-Cat* mutants ([@bib137]), and the Arp2/3--WAVE/SCAR complexes associate with E-cad clusters and regulate their endocytosis ([@bib162]; [@bib75]; [@bib83]). In fact, *D*E-cad endocytosis is enhanced in a Rho1-dependent manner when junctions are under stress and *D*E-cad clusters are also down-regulated via inhibition of Par3 by Rok ([@bib85]; [@bib83]). Our results are in agreement with a role of Arp2/3 in regulating ZA stability in the AS. Heterozygosity of *SCAR^∆37^, Arp1^Q25st^* or *Arp3^EP3640^* not only partially restored *D*E-cad::GFP localisation at the ZA in the AS of *foscrb~Y10A~* embryos and suppressed DC defects, but even rescued the lethality of *foscrb~Y10A~* flies. Fusion of abdominal segments in adult escapers suggest that Crb may also be involved in histoblast fusion during metamorphosis ([@bib94]; [@bib112]). Myosin-II activity itself has also been shown to be essential for the maintenance of AJs in some cases. Mice ablated for NMHC II-A die by E7.5 due to massive defects in cell-cell contacts and epithelial multi-layering accompanied by loss of E-cad and β-catenin from adhesion sites ([@bib24]). Similarly, ZA stability in the *Drosophila* embryonic ectoderm depends on myosin-II contractility and requires interactions with actin ([@bib31]; [@bib159]). Finally, Rok and myosin-II activities participate in ZA remodelling in the *Drosophila* pupal eye by regulating the formation of *D*E-cad recycling endosomes ([@bib174]). Because the SCAR-Arp2/3 complex is an important enhancer of actin protrusions ([@bib172]; [@bib1]; [@bib38]), it is also plausible that reducing its activity in *foscrb~Y10A~* embryos stabilises the ZA indirectly.

On the other hand, misregulation of actomyosin activity is not always associated with defects in ZA stability and integrity of the AS. Expressing a constitutively active form of MLCK to increase myosin II activity or over-expression of RhoGEF2, an activator of Rho1, results in an increase in the number and density of actin foci without affecting the integrity of the AS ([@bib5]; [@bib33]), which could be due to the use of a weak GAL4 driver. Alternatively, the difference to our results could be explained by the fact that these authors performed the over-expression in a background with more than two copies of E-cad (using a ubi-*D*E-cad::GFP line), while we performed the experiments in a knock-in *D*E-cad::GFP line ([@bib60]; [@bib59]), which thus may represent a more sensitive background.

Crb--an organiser of a platform to link the ZA with the actomyosin network? {#s3-3}
---------------------------------------------------------------------------

Another possibility to interpret our results is that Crb, or an interacting protein, couples the actomyosin network and the ZA. During gastrulation in *C. elegans* a molecular clutch has been postulated to connect the myosin network with the adhesion sites to transmit the force generated by the actomyosin contractions ([@bib133]). In *Drosophila*, the actomyosin contractions in the AS are initially uncoupled from apical contractions and hence the ZA ([@bib146]; [@bib42]; [@bib11]). Successive rows of amnioserosa cells are then sequentially stabilised in a contracted state, driving further contraction of the tissue. The surface stabilization mechanism is not known, but is likely to involve an increase in cellular stiffness \[reviewed in ([@bib114])\]. In *foscrb~Y10A~* embryos the actomyosin foci in the AS emerge prematurely before the onset of germ band retraction, whereas in wild-type these foci are more abundant after the end of germ band retraction ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and data not shown). Thus, the early over-contraction of the actomyosin in *foscrb~Y10A~* embryos may induce a premature coupling to the ZA, thus disrupting germ band retraction and DC. An interesting candidate for this coupling is the protein Canoe, which binds to α-catenin ([@bib139]; [@bib118]), and whose absence results in a DC phenotype ([@bib67]; [@bib150]; [@bib14]; [@bib22]). Absence of Canoe induces the detachment of the actomyosin apparatus from cell-cell junctions during *Drosophila* mesoderm invagination ([@bib139]; 2011).

In conclusion, we show a novel function of the FBM of Crb as an essential regulator of cytoskeleton dynamics and tissue integrity during DC. Different lines of evidence show that Crb regulation of AS morphogenesis involves *D*Moesin, Rho-GTPases, class-I Pak, and the SCAR-Arp2/3 complex. Further work will determine at which level Crb regulates actomyosin dynamics and why it is just the morphogenesis of the AS that depends on the FBM of Crb, while all other embryonic epithelia are not affected.

Materials and Methods {#s4}
=====================

Fly stocks (see [Table 2](#tbl2){ref-type="table"}) {#s4-1}
---------------------------------------------------

10.7554/eLife.07398.042

###### 

List of fly stocks used in this study.

**DOI:** [http://dx.doi.org/10.7554/eLife.07398.042](10.7554/eLife.07398.042)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Fly stock                           Description
  ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *w*                                 All stocks have the *w\** or *w^1118^* background

  *w;foscrb*\                         Flies expressing fosmid variants of crb under the control of the endogenous promoter and inserted into the landing site *attP40* on 2^nd^ chromosome; described in ([@bib72])
  *w;foscrb~Y10F~*\                   
  *w;foscrb~Y10A~*                    

  *w;;crb^11A22^/TTG*                 *crb* null allele; BSC 3448

  *w;;crb^GX24^/TTG*                  *crb* null allele ([@bib60])

  *w;;yrt^∆75a^crb^11A22^/TTG*        *yrt* protein null allele recombined with the *crb^11A22^* allele ([@bib81])

  *w;;puc^E69^/TTG*                   lacZ enhancer trap in the *puc* locus, a read-out of JNK signalling ([@bib128]; [@bib98])

  *w;SCAR^∆37^/CTG*                   Loss of function allele ([@bib177]); BSC 8754

  *w;;Arp3^EP3640^/TTG*               generated by Berkeley *Drosophila* Genome Project ([@bib61]); BSC 17149

  *w;ex^697^/CTG*                     lacZ enhancer trap in the *ex* locus; kindly provided by Nick Tapon

  *w;nub^1^Arpc1^Q25st^ FRT40A/CTG*   Nonsense mutation at Gln25 (CAG→TAG); behaves as a null mutant ([@bib61]); BSC 9135

  *w flw^6^/FTG*                      Amorphic allele ([@bib120]); BSC 23693

  *y w rok^2^ FRT19A/FTG*             Encodes the first 21 amino acids of rok followed by a 35 aa random peptide and a stop codon ([@bib169]); BSC 6666

  *w;Rho1^1B^/CTG*                    *Rho1* loss of function allele; BSC 9477

  *w;DE-cad::GFP*                     DE-cadherin fused with GFP knock-in allele; homozygous viable ([@bib60])

  *w;DE-cad::mTomato*                 DE-cadherin fused with mTomato knock-in allele; homozygous viable ([@bib60])

  *w;Zipper::GFP*                     Protein trap line: Zipper fused with GFP under endogenous promoter; homozygous viable; BSC 51564.

  *w;sqh::Utrophin::GFP*              Actin binding domain of human Utrophin fused with GFP under the control of the *sqh* promoter ([@bib121]).

  *w;;Sas::Venus*                     On 3^rd^; Stranded at Second fused with Venus under tubulin promoter ([@bib32])

  *w; GAL4^332.2^*                    On 2^nd^; expresses GAL4 in amnioserosa; BSC 5398

  *w; UAS-Apoliner*                   On 2^nd^; engineered apoptotic reporter ([@bib7]); BSC 32122

  *w; UAS-flw-HA*                     On 2^nd^; HA-tagged flw protein under UAS control; BSC 23703

  *w;; UAS-Rho1^N19^*                 On 3^rd^; dominant negative Rho1 under the control of UAS; BSC 7328

  *w;; UAS-Rac^N17^*                  On 3^rd^; dominant negative Rac under the control of UAS; BSC 6292

  *w; UAS-Cdc47^N17^*                 On 2^nd^; negative Cdc42 under the control of UAS; BSC 6288. The stock *w;DE-cad::GFP,UAS-Cdc42^N17^/(CTG);crb^11A22^,UAS-Actin::RFP/TM6B-YFP* or *TTG* was not possible to obtain, probably because the expression of Cdc^N17^, induced by the GAL4 from the balancer chromosome is detrimental.

  *w;; UAS-moe^T559D^-myc*            On 2^rd^; phosphomimetic Moesin under the control of UAS; BSC 8630

  *w;; UAS-moe-myc*                   On 3^rd^; myc-tagged Moesin under the control of UAS; BSC 52236

  *w; UAS-Pak-myr*                    On 2^nd^: constitutively-active, membrane-bound Pak under UAS control; BSC 8804

  *w; UAS-Pak-AID*                    On 2^nd^; Pak autoinhibitory domain under UAS control; kindly provided by Nicholas Harden ([@bib23])

  *w;; UAS-Act::RFP*                  On 3^rd^; RFP-tagged Act5C under UAS control; BSC 24779

  *w;; UAS-rok-CAT-KG*                On 3^rd^; a kinase-dead rok under UAS control; BSC 6671

  *FTG*                               Balancer on 1^st^ *FM7c, twi-GAL4 UAS-EGFP*; from BSC 6873

  *CTG*                               Balancer on 2^nd ^*CyO, twi-GAL4 UAS-EGFP*; from BSC 6662

  *TTG*                               Balancer on 3^rd ^*TM3, twi-GAL4 UAS-EGFP Sb^1^ Ser^1^*; from BSC 6663

  *TM6B-YFP*                          Balancer on 3^rd^*TM6B, Dfd-EYFP, Sb^1^ Tb^1^ ca^1^*; from BSC 8704
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BSC - Bloomington stock center; DGRC - Drosophila Genetic Resource Center.

Flies were maintained at 25ºC on standard food. All the mutant alleles where balanced over fluorescent balancers to identify the homozygous mutants in fixed embryos or live imaging microscopy (see below). All crosses and analyses were carried in a *crb* null background (*crb^GX24^* or *crb^11A22^*, homozygous or trans-heterozygous), so the expression of the different variants of Crb is exclusively provided by the fosmid ([@bib72]). The different UAS-lines where recombined with the *D*E-cad::GFP knock-in allele or the null *crb^11A22^* allele. The driver line GAL4^332.3^ was recombined with each of the different fosmid alleles.

Embryo collection and antibody staining {#s4-2}
---------------------------------------

Embryo stage refers to the *foscrb;crb^GX24^* genotype morphology accordingly to ([@bib20]). All genotypes (*foscrb;crb^GX24^, foscrb~Y10F~;crb^GX24^* and *foscrb~Y10A~;crb^GX24^*) were collected under the same conditions, at the same time and during the same period (indicated in the respective figure legend). In this way, the comparison between *foscrb* or *foscrb~Y10F~* and *foscrb~Y10A~* mutant phenotypes show the differences observed at a specific time after egg laying. Embryos were collected on apple juice plates at 25ºC and then incubated for the appropriate times at 25ºC or 28ºC, dechorionated in 3% sodium hypochlorite for 3 min, fixed for 20 min in 4% formaldehyde in phosphate-buffered saline (PBS) solution/heptane V/V 1:1. Vitelline membrane was removed by strong shaking in heptane/methanol v/v 1:1, except for the staining of actin in which the vitelline membrane was removed by strong shaking in 80% ethanol. Embryos were blocked for 2 hr at room temperature in PBT (PBS + 0.1% Triton X-100) + 5% normal horse serum (Sigma-Aldrich H1270, St. Louis, Missouri, USA). Embryos were incubated for 2 hr at room temperature or overnight at 4ºC with primary antibodies (see [Table 3](#tbl3){ref-type="table"}). For analysis of Zipper localisation, we used the protein trap line *Zipper::GFP* (see [Table 2](#tbl2){ref-type="table"}) and the staining was done using the anti-GFP antibody. Incubations with the appropriate secondary antibodies were performed for 1 hr at room temperature. Stained embryos were mounted in glycerin propyl gallate (75% glycerol, 50 mg/mL propyl gallate) and visualized using a Zeiss LSM 780 NLO confocal microscope (ZEISS Microscopy, Jena, Germany) with a C-Apochromat 40x/1.2W Corr objective with the correction collar at 0.18 (at this position the brightness and contrast was enhanced). To distinguish homozygous embryos, in all the stainings an anti-GFP antibody was included to stain for the balancer-provided GFP. All images for a given marker in different genotypes were taken under the same settings for laser power, PMT gain and offset. Maximal projections, merging and LUT-pseudocolor assignment was performed using Fiji ([@bib140]). For the FIRE-LUT pseudocolor 0 is black and 255 is white. Mounting was done in Adobe Photoshop CC 2015.0.1 and when brightness and contrast was adjusted, the modifications were equally applied to all the set of images for a given marker.10.7554/eLife.07398.043Table 3.Antibodies and probes employed.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.043](10.7554/eLife.07398.043)DilutionSourcePhalloidin Alexa Fluor 5551:500InvitrogenAlexa Fluor 488-, 568-, and 647-conjugated1:500Invitrogen*Rat antibodies*anti-Crb2.81:500([@bib124])anti-*D*E-cadherin1:20DSHB DCAD2anti-Yurt1:100([@bib81])*Mouse antibodies*anti-α-Spectrin1:25DSHB 3A9anti-β-galactosidase1:200DSHB 40-1aanti-Coracle1:25DSHB C566.9anti-Crb-Cq41:300DSHB Cq4anti-Disc large1:100DSHB 4F3anti-Enabled1:100DSHB 5G2anti-GFP1:500Roche 11814460001 (Mannheim, Germany)anti-Hindsight1:100DSHB 1G9anti-Integrin β~PS~1:2DSHB CF.6G11anti-Phosphotyrosine1:100BD Transduction Laboratories cat. no. 610000anti-SCAR1:25DSHB P1C1*Rabbit antibodies*anti-Bazooka1:500kindly provided by A. Wodarzanti-DAAM1:3000kindly provided by József Mihály (unpublished)anti-Diaphanous1:5000kindly provided by Steven A. Wasserman ([@bib3])anti-*D*Patj1:1000([@bib124])anti-Echinoid1:5000kindly provided by Laura Nilson ([@bib79])anti-Expanded1:300([@bib13])anti-GFP1:500Invitrogenanti-*D*Pak1:8000kindly provided by Nicholas Harden ([@bib46])anti-Polychaetoid1:5000kindly provided by Sarah Bray ([@bib28])anti-Phospho-Moesin1:100Cell Signaling Technology 3150 (Danvers, Massachusetts, USA)anti-Stranded at second1:500kindly provided by E. Organ and D. Cavener[^2]

Cuticle preparation {#s4-3}
-------------------

Embryos were collected overnight on apple juice plates at 25ºC and then incubated for \> 6 hr at 28ºC. All the GFP or YFP positive eggs (the GFP or YFP is provided by the balancer) were removed and the remaining eggs where maintained at 25ºC. The next day, the plates were screened again to remove remaining GFP/YFP positive eggs/larvae. Thus, all the remaining eggs/larvae had a *crb* null background (*crb^GX24^* or *crb^11A22^*, homozygous or trans-heterozygous). These eggs/larvae were collected, dechorionated in 3% sodium hypochlorite for 3 min, mounted on Hoyer's medium (gum arabic 30 g, chloral hydrate 200 g, glycerol 20 g, H~2~O 50 ml), and the slide was incubated overnight at 60ºC. In this way, all the eggs laid in the plate were at least \>28 hr at 25º, enough time to let the larvae hatch when they are viable. The preparations were analysed by phase contrast with a Zeiss Axio Imager.Z1 microscope with an EC Plan-NEOFLUAR 10X/0.3 objective.

Scanning electron microscopy (SEM) {#s4-4}
----------------------------------

Embryos were collected on apple juice plates for 1 hr at 25ºC and then incubated for 8 hr at 28ºC, dechorionated in 3% sodium hypochlorite for 2 min 30 sec, and fixed for 30 min in 25% glutaraldehyde/heptane v/v 1:1. Devitellinization was done by hand in 25% glutaraldehyde. Then, the embryos were postfixed in modified Karnovsky (2% paraformaldehyde/2% glutaraldehyde in 50 mM HEPES) followed by 1% osmium tetroxide in PBS, dehydrated in a graded series of ethanol, transferred to microporous capsules (78 μm pore size, Plano Cat. 4614) and critical point dried using the Leica CPD 300 (Leica Microsystems GmbH, Wetzlar, Germany). Embryos were mounted on 12 mm aluminium stubs and sputter coated with gold using a Leica Baltec SCD 050. Samples were analysed with a Jeol JSM 7500F cold field emission SEM (JEOL Ltd, Tokyo, Japan) at 10 kV acceleration voltage.

Live imaging {#s4-5}
------------

Embryos were collected and incubated as describe above (see \'Embryo collection and antibody staining\'). In the analysis of pulsed contractions in the AS, sequential collections of 30 min interspaced by 1 hr between each genotype allowed us to analyse 2--3 embryos of each genotype on the same session, so the acquisition conditions for all the genotypes were identical. To eliminate *crb^GX24^* or *crb^11A22^* heterozygous embryos, all GFP or YFP positive embryos were removed. The remaining eggs were dechorionated by hand or in 3% sodium hypochlorite for 2 min, mounted and oriented in a bottom glass Petri dish (MatTek P35G-1.5.14-C, Ashland, Massachusetts, USA). Previously, the glass was cover with a thin layer of glue (adhesive dissolved from double sided tape in heptane). The embryos were covered with water and visualized by multi-position scanning using a Zeiss LSM 780 NLO confocal microscope with a W Plan-Apochromat 40x/1.0 objective. Excitation was performed with 488 nm for GFP or YFP, and 561 nm for RFP or mTomato from an Argon Multiline Laser. The pinhole was adjusted for faster acquisition, so the step sizes correspond to 2.01 μm ([Videos 1](#media1){ref-type="other"}, [2](#media2){ref-type="other"}, [7](#media7){ref-type="other"}, [11, 13](#media11){ref-type="other"}, [14](#media13){ref-type="other"}), 2.3 μm ([Videos 4](#media4){ref-type="other"}, [5](#media5){ref-type="other"}, [6](#media6){ref-type="other"}), 1.2 μm ([Video 8](#media8){ref-type="other"}, [12](#media12){ref-type="other"}), 1.46 μm ([Videos 3](#media3){ref-type="other"} and [9](#media9){ref-type="other"}). 4D-Hyperstacks were processed with Fiji ([@bib140]) and the movies were rendered with Adobe Photoshop CC 2015.0.1. Under these conditions we observed that *w;foscrb,DE-cad::GFP;crb^GX24^* embryos imaged for \>7 hr at 5 min time lapse hatched and survived without showing any obvious damage (data not shown).

Statistical analyses {#s4-6}
--------------------

Statistical analyses were performed with GraphPad Prism 6. Results are expressed as means ± SD. Statistical significance was evaluated in a one-way analysis of variance (ANOVA) followed by a Dunnett's multiple-comparison test. In the analysis of the statistical significance of the data presented in the [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, the percentages were first converted to arcsin values and then analysed by a one-way-ANOVA followed by a Dunnet's multiple comparisons test.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Crumbs is a negative regulator of amnioserosa contractions during dorsal closure in *Drosophila*\" for peer review at *eLife*. Your submission has been favorably evaluated by K VijayRaghavan (Senior editor, who also served as Reviewing editor and reviewer) and three other reviewers.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Summary of paper:

In this manuscript, Flores-Benitez and Knust examine the specific phenotypes associated with a crumbs allele, *foscrb~Y10A~*, which leads to aberrant dorsal closure. The authors examine the role of this allele in relation to the major known mechanical and signaling pathways for dorsal closure: the DME supracellular actin cable, DME leading edge protrusions, contractions of the amnioserosa, and the JNK pathway. The authors find that JNK signaling is essentially intact, while the DME supracellular actin cable, and DME protrusions are disrupted, with mostly expected changes to proteins known to mediate these structures. In regards to the amnioserosa itself, the authors find that this structure has disrupted zonula adherens and, through a series of rescue experiments, conclude that the major defect is due to excessive Rho-mediated amnioserosa contractions.

Overview of referee comments:

The reviewers agree that that this is potentially good work and in revised form could be of interest to a large audience. For a substantially revised manuscript to make a valuable contribution to *eLife* there are several major issues, including important controls that need to be addressed.

The authors need to improve the delivery if they want this paper to have the impact they want it to have. As presented, it is difficult to read and experimentally incomplete. Part of the problem is that paragraphs are not very well structured and topic sentences don\'t adequately describe the topics addressed in the paragraph. Thus the reader is expecting to learn about one thing but data and details are presented regarding many others. Part of the problem may also be that the authors have presented a lot of material (too much material?) and as a consequence, the presentation is not as clear or complete as it might be. There are in addition some technical problems with the data as presented. The authors should focus on presenting their findings more clearly and more completely, potentially removing some findings in order to better document and provide appropriate controls on other findings.

The domain-specific phenotypes are the major thrust of the paper. Therefore the authors must with clarity establish that the phenotypes are due to the mutant domain (the authors still need to verify that the protein is properly folded and trafficked to conclude that the phenotypes are domain- and not simply crb- specific). Better showing the localization of the mutant protein at higher resolution and in all tissues would be valuable. Presumably, in tissues that are unaffected, it should look precisely like the wild type or the Y10F variant.

Having done this, the authors need to carefully discuss direct- and indirect- phenotypes, making sure that they are not over-interpreted. The rescue experiments with Rho and Flw suggest that there could be a more direct effect on actomyosin activity on top of the adhesion defects. In this context it is important that the major conclusion that Crumbs is negatively regulating Rho1 should be tested directly (see specific comments below). The \"meat\" of the manuscript lies on the set of rescue experiments of dorsal closure, and particularly of amnioserosa morphogenesis. However, the authors make the analysis of the defects at the level of dorsal epidermal cells an important part of the work which then seems to be set aside. The inclusion of the section describing AS cells becoming migratory is not salient to the authors\' major points, but is a bold statement with the data presented. They should remove this section from the paper or provide additional control experiments to show these cells are not escaping hemocytes.

Specific Comments:

Reviewer 1:

This paper provides convincing phenotypic evidence for the crumbs allele *foscrb~Y10A~*causing defects to the DME supracellular actin cable, DME protrusions, and amnioserosa over contractions. However, a major concern is that there is little evidence that all of these strikingly documented phenotypes are not secondary to the adhesion defects found here and expected in a crumbs allele. As such, some of the conclusions are overstatements of the data presented.

1\) While the images and movies provided are often striking, quantification would be helpful especially in DME phenotypes. For instance, in Figure 20 the authors highlight cells, which masks the ability to judge expression independently; a line profile across these cells and adjacent cells would helpful. Similarly, the differences in cadherin clustering in [Figure 3A-F](#fig3){ref-type="fig"} are hard to gauge in the picture shown and would benefit from quantification.

2\) The conclusion that Yurt is uninvolved because its phenotype is qualitatively less severe could be explained by it only being involved in a subset of activities. Combining *foscrb~Y10A~* with a yurt allele could easily test this possibility.

3\) The finding that amnioserosa cells are becoming motile is very striking. However, these cells resemble hemocytes, especially in the SEM pictures. If the amnioserosa has holes in it, as well as prematurely apoptotic cells, it would be expected for hemocytes to be responding to clear this cellular debris. The authors should confirm that the mobile cells are not hemocytes or tone down this section.

4\) The major conclusion that Crumbs is negatively regulating Rho1 should be tested directly, especially considering some of the surprising results in the rescue experiments where Rok, loss of function Rho1 and Rho1 dominant negative alleles do not give similar results. Is Rho1 or active Rho1 increased in the *foscrb~Y10A~* background?

*Reviewer 2:*

This is a compelling, interesting and rigorously crafted work that reports novel and important information that will be of interest to a large audience. I enjoyed very much reading this work which opens up several research avenues to unravel the molecular mechanisms underlying amnioserosa cell apical contraction. I only have a couple of questions:

1\) The authors say that Crumbs is a negative regulator of actomyosin dynamics and report an increase in the number of myosin (Zipper) foci, which persist longer and are more disorganized. I wonder if actin localization also follows this aberrant dynamics. It is very likely that it does so, but it may be good to check.

2\) Regarding the defects of epidermal cells that are in contact with the amnioserosa and the disorganization of the actin cable and filopodia in *foscrb~Y10A~* embryos, the authors seem to favor the idea that they are a secondary effect due to defects in the contraction of the amnioserosa. Although I agree that some of the observed defects can be attributed to a failure in amnioserosa morphogenesis (i.e. *D*E-Cadherin localization), I think that some of the defects could be due to a specific function of Crumbs in these cells. In this sense, I wonder whether the authors have observed any differences in the organization of the dorsal epidermis in the different rescue experiments performed, i.e. is the actin cable, filopodia formation or Ena localization differentially restored when Flw is ectopically expressed in the AS or when one copy of *SCAR, Arp3* or *Arpc1* is removed from fo *foscrb~Y10A~* embryos?

*Reviewer 3:*

A substantially revised manuscript with some additional controls may well make an excellent contribution to *eLife*.

1\) A previous finding was that a fosmid covering the entire crumbs (*crb*) locus, *foscrb* or a variant that replaces a conserved tyrosine with phenylalanine (*foscrb~Y10F~*), but not alanine (*foscrb~Y10AI~*) could completely rescue the embryonic lethality, germband retraction, dorsal closure and head involution defects that characterize homozygous, *crb* null animals. They evaluate *crb* function in detail by analyzing *foscrb* and variant rescue of *crb* null specimens using live imaging of a knockin allele of *D*E-cadherin, *D*E-cadGFP. The *foscrb~Y10A~* animals show major defects in germ band retraction, have a highly disorganized amnioserosa which is lost over time. Ultimately dorsal closure fails. The authors do not make clear why they have chosen to analyze two variants, Y10F, which in all cases mimics the wild type Y10 variant and Y10A, which in all cases behaves quite differently. They should explain why they are evaluating Y10F and might save considerable space by simply reporting that the Y10F variant behaves like the wild type Y10 in all cases (perhaps I missed where it did not?).

2\) Next, they examine a role for Yrt, a candidate FERM domain protein that may act in concert with Crb. Normally, Crb, *D*Patj and Yrt are expressed at higher levels in the epidermis than the amnioserosa, but are largely absent from the leading edge of the dorsal most cells. In the Y10A animals, the DMEs fail to elongate properly and Crb and *D*Patj are associated with the leading edge, particularly in cells that remain short. In contrast, Yurt is absent from the leading edge in normal and Y10A animals. In addition, the authors find that the *yrt* mutant phenotype is different than the Y10A mutant phenotype, which they state starts earlier and is more complex than the *yrt* phenotype. They conclude the *yrt* seems not to be involved with the phenotype of Y10A embryos (this is not convincing, see specific comments below).

3\) Next the authors demonstrate that a key feature of the Y10A phenotype is the absence of filopodia at the leading edge and conclude that *crb* function is required for normal microvilli.

4\) The authors then turn their attention to how *crb* functions in the localization of echinoid and the formation of the actomyosin rich cable in the DME cells. They describe changes in echinoid distribution and report alterations in Baz distribution that are not particularly convincing. In addition they found that *yrt*, coracle and Dlg distributions were normal in all fosmid variants and conclude that *crb* is not responsible for specifying their localization.

5\) Next, the authors evaluate *D*E-cadherin localization in the *foscrb* variants and report that in *foscrb* and Y10F *D*E-cad localizes at all cell-cell contacts, including at the LE, but fail to discuss the normal loss of *D*E-cad from the leading edge later in closure. Have they evaluated *D*E-cad distributions throughout closure (it changes dramatically)? The authors report that *D*E-cad at the LE and in the amnioserosa is reduced it the Y10A animals. Their conclusion that Y10A animals lack the actomyosin apparatus of the LE is certainly justifiable, but they should refine their conclusions about adhesion based on better characterization of the *D*E-cad distributions at early and late stages of closure.

6\) The authors also evaluate the state of the amnioserosa in Y10A mutants and report that there are discontinuities in the distribution of *D*E-cad on AS borders and that there are large intracellular clusters of *D*E-cad in the Y10 animals (however, see comments below). Because germband retraction fails in these embryos, it is not clear that the defects reported are due to defects in dorsal closure per se and the authors should rethink their conclusions as a consequence.

7\) Next the authors evaluate the integrity of the amnioserosa. They do not really explain why they used imaging of the microtubule binding protein Jupiter to do so (no comment on microtubule distribution or function is present, so the reader is left wondering). Nevertheless, they find that while extensions of the amnioserosa over the epidermis characterize all three variants of *foscrb, wt* and Y10F extensions are resolved during closure, but the in Y10A animals they are not. Again, a reasonable possibility seems to be that the amnioserosa is falling apart and because germ band retraction and dorsal closure have not progressed in Y10A animals that the AS cells take on the random migration phenotype. The SEMs presented confirm that aberrant nature of the apical surfaces of the AS cells that is consistent with their entering apoptosis. This may be because they are prematurely apoptotic or instead that they are undergoing apoptosis at an \"appropriate\" time, but germ band retraction and dorsal closure is delayed. Can the authors reference other developmental stages that confirm or refute this interpretation?

8\) They next evaluate apoptosis and conclude that apoptosis is premature in Y10A embryos. For reasons detailed below, their data are not convincing on this point.

9\) They also evaluate JNK signaling using *puc-LacZ* which is a biomarker for JNK signaling. They show convincingly that *puc-LacZ* localization is aberrant in Y10A embryos, most likely as a consequence of the abnormal elongation of DME cells. However, because there is the same number of *puc-lacZ* positive nuclei in the Y10A animals, the authors appear to conclude that JNK signaling is normal. Nevertheless, they never explicitly say that JNK signaling is normal in the Y10A embryos.

10\) The authors go onto evaluate pulsed contractions of the amnioserosa cells. Videos and stills confirm that the individual cells in Y10A embryos are hard to discern. Nevertheless, there are pulsed contractions that are occurring in *D*E-cad labeled embryos. In addition, the zipGFP labeled embryos show clear, pulsed formation of myosin foci that subsequently disperse. The authors note that the period of the formation and dispersal of foci is very irregular in the Y10A embryos and the movies and kymographs are consistent with that observation. However, such movies and kymographs (of selected foci) do not give a sufficiently quantitative overview of the effect. The authors should quantify periods for randomly chosen foci in the wt, Y10F and Y10A cells. At least tens of foci should be analyzed, if not a hundred or so. Histograms of observed periods for foci formation and dissolution would be essential for drawing the conclusions that they subsequently draw as to the role of *crb* FBM in regulating actomyosin.

11\) The authors show that over expression of Flapwing, a phosphatase for phospho-sqh, suppresses the Y10A failure in germ band retraction and dorsal closure. This is a very interesting finding and provides the most compelling evidence that *crb* mediates its effects through regulation of myosin contractility. Nevertheless, it is somewhat surprising that the authors did not evaluate better the effects of flapwing expression on the integrity of the amnioserosa cells (as assayed in *D*E-cad-GFP expressing embryos). Thus, [Figure 5](#fig5){ref-type="fig"} panels M-O are at very low magnification and quality such that the integrity of the AS cells and the *D*E-cad-GFP adhesion junctions cannot be ascertained. The authors should present movies comparable to [Video 10](#media10){ref-type="other"} with flapwing over expression and should also evaluate quantitatively the period of pulsed contractions in the flapwing over expressing embryos (for wt, Y10F and Y10A embryos).

12\) To understand the mechanisms by which myosin is phosphorylated, the authors turn their attention to three effectors of small GTPases in the Rho/Rac/Cdc42 family, Rok, *D*Pak and Scar. They present data in a table that is part of [Figure 6](#fig6){ref-type="fig"}. It is not easy to follow is only poorly referenced in the text. First, there are no error bars on the numbers presented. 71.3% or 70.5% really different than one another (probably not)? Are they different from 59.7 or 56.5 (without error bars, not possible to know)? My interpretation of the first 3 rows of the table is that the expression of *UAS-Actin-RFP*, under the control of an amnioserosal driver (I shouldn\'t have to reference another table to figure out where Gal4-332.2 is expressed) substantially suppresses the most severe dorsal open phenotype (i.e., from 59.7 to 18.5), but the authors don\'t comment on that. Perhaps they want us only to focus on the penetrance of the wt-like phenotype? If so they should explicitly say so and they should consider pooling the defects into a single dorsal open category, perhaps relegating the more detailed panel to supplementary material). Moreover, where they do explicitly draw our attention to changes, the comparisons seem flawed. They ask us to compare row 4 to row 3 to show that *UAS-crb* expression increases the most severe dorsal hole, but the embryos in row 4 don\'t express *UAS-actin-RFP* and the expression of *UAS-actin-RFP* greatly affects the number of animals in the most severe category (compare row 3 to rows 1 and 2). Similarly, rows 9 and 10 are compared to 3, but 9 and 10 don\'t express *UAS-actin-RFP*. Similarly, are differences seen with *UAS-moe* (without actin) vs. UAS phosphomimetic moe (with actin) simply due to the expression of actin? If I understand [Figure 6](#fig6){ref-type="fig"} correctly, experiments are not being compared to appropriate controls.

13\) Nevertheless, some of the data show intriguing trends. Over expression of the autoinhibitory domain of *D*Pak suppresses the DC phenotype of Y10A animals, whereas over expression of *D*Pak induces a DC phenotype in otherwise normal embryos. Is it correct that autoinhibition of *D*Pak is intra-molecular? If so isn\'t it surprising that the autoinhibitory domain is effective when presented as a separate protein? How overexpressed is the domain?

Other key data are the suppression of Y10A DC phenotypes by the overexpression of *D*E-Cad.

14\) Subsequent analysis of the role of Arp2/3 is focused on Arp2/3\'s role in endocytosis and is interpreted vis-à-vis the endocytosis of *D*E-cad. Lamelipodia and filopodia are a key feature of both the leading edge and amnioserosal tissues and Arp2/3 may have key roles in their function independent of their role in endocytosis. Why do the authors attribute the effects of Arp2/3 solely on endocytosis?

15\) Finally, the authors conclude that *crb* function impacts both actomyosin dynamics and adhesion, and that the two effects may be inter-related, but the title of their paper suggests only a role in regulation of actomyosin dynamics. It is not clear why this is appropriate. While they use the Discussion to argue their point, it seems that a revised Results text, with some experimental revision may alter the conclusions made in the Discussion substantially. At this point their title should be revised to more accurately reflect the firm conclusions made in the Results and leave the speculation in the Discussion clearly marked as such.

In addition to these general comments, I make the following specific points for the Introduction and part of the Results. I incorporated comparable specific comments into the more general comments above for the remainder of the results but found that detailed comments were becoming both too numerous and too complicated.

In the subsection "The FBM of Crb is essential for dorsal closure", first paragraph: The authors conclude the FERM binding domain of *crb* is responsible for the effects that they see because a point mutation (Y10A) in the FBD fails to rescue *crb* mutant function. Do they know that the alanine variant is made and correctly trafficked to the plasma membrane? If so, they should say how they know that and provide a reference. Otherwise conclusions regarding FBD function (vs. *crb* function as a whole) are erroneous.

Certainly dorsal closure fails in these Y10A animals ([Figure 1C-I](#fig1){ref-type="fig"}), but germ band retraction is far from complete. Moreover, in normal embryos, the amnioserosa undergoes apoptosis upon completion of closure. Are the defects in closure observed due to the fact that at the posterior end the canthus does not form properly because of the incompletely retracted germ band and because the amnioserosa undergoes apoptosis thereby blocking closure? This puts a different spin on the defects observed.

In the subsection "The FBM of Crb is essential for dorsal closure", the authors state that \"Of these protein species, Yrt appeared as a likely candidate responsible for the defects in the *foscrb~Y10A~* mutant, since Yrt negatively regulates Crb (Laprise et al., 2006), zygotic *yrt* mutant embryos show DC defects (Hoover and Bryant, 2002), and over-expression of Crb in the amnioserosa results in DC defects (Harden et al., 2002; Wodarz et al., 1995)". I don\'t understand how \"over-expression of Crb in the amnioserosa results in DC defects\" makes Yrt a likely candidate? The manuscript is characterized by a number of statements such as this one that distracts the reader and detracts from the message that the authors are trying to deliver.

In the subsection "The FBM of Crb is essential for dorsal closure", fifth paragraph: The authors should show on the schematic in [Figure 1](#fig1){ref-type="fig"} the orientation of the cross sections shown in [Figure 1](#fig1){ref-type="fig"} panels M, N and O. Neither the text, nor the figure legend adequately describes the orientation of the section, and how it was obtained. Thus it is hard for the reader to understand what these panels are trying to show.

In the subsection "The FBM of Crb is essential for dorsal closure", the authors state: \"Moreover, in *foscrb* and *foscrb~Y10F~* lacking zygotic *yrt* DC fails only after GB retraction, which is qualitatively different from the phenotype of *foscrb~Y10A~* or *foscrb~Y10A~* embryos lacking zygotic *yrt* ([Video 4](#media4){ref-type="other"})\". The authors should state explicitly how the phenotypes are qualitatively different and explicitly state whether or not the Y10A phenotype differs in the presence or absence of zygotic *yrt*. In addition the next sentence \"These results suggest that the DC phenotype of *foscrb~Y10A~* embryos starts earlier and is more complex than that in *yrt* mutants\" requires the authors to give us more details about the *yrt* phenotypes, which are only referenced and not adequately described. I found this paragraph very hard to get through. The authors should consider reworking it for clarity.

In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", first paragraph: The authors should provide a reference or other explanation of why Sas stains filopodia. Also, given that the core of microvilli consists of actin filaments, I don\'t understand why microvilli are not visible in the *foscrb* and Y10F animals ([Figure 2G and H](#fig2){ref-type="fig"}). (Under appropriate conditions, ena might also be visible in the microvilli, but previous reports suggest it is visible primarily if ena is over expressed).

In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", the authors state: \"The formation of the actomyosin cable at the LE depends on the asymmetric accumulation of the adhesion protein Echinoid (Ed) in the DME cells (Laplante and Nilson, 2011; Lin et al., 2007)". As written only readers familiar with the referenced work will realize that the asymmetry of Ed protein in the DME cells is not normal and that it is asymmetry in the distribution of Ed between the epidermis and the amnioserosa that is relevant. They also state that \"Removal of Ed from the LE is evident in *foscrb* and *foscrb~Y10F~* embryos ([Figure 2J, K](#fig2){ref-type="fig"}, arrowheads mark Ed absence at the LE)\", but Ed is also not present at the leading edge of the DME cells in Y10A animals. Moreover, the data presented in [Figure 2O](#fig2){ref-type="fig"} is not at all convincing. Baz is present at the leading edge of only one Y10A cell and it is possible that the dark line shown is background, like the line just above the arrow, deeper in the amnioserosa.

In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", sixth paragraph: Gorfinkiel and Arias 2007 show very convincingly that *D*E-cad initially localizes to the LE, but later during closure is lost from the leading edge (see Gorfinkiel and Arias [Figure 1](#fig1){ref-type="fig"}). The authors need to verify that their observations on the fosmid rescue embryos are consistent with the literature and consider how clearing the leading edge of *D*E-cad is consistent with the mechanisms they propose here. Moreover, the quality of the *D*E-cad stained images lacks contrast (compare Gorfinkial and Arias, Figure Aiii and Biii to this manuscripts [Figure 2P, Q and R](#fig2){ref-type="fig"}). Better stained preparations might give better insight into *D*E-cad distributions in the Y10A animals.

In the subsection "The FBM of Crb is essential for the morphogenesis of the AS", second paragraph: The authors claim that there are discontinuities in *D*E-cad localization in Y10A animals which appears to be the case, although if the structure of the AS is considerably different than wildtype. How do the authors know that the *D*E-cad junctions haven\'t simply gone out of the plane of section? Moreover, the authors cite large aggregates of *D*E-Cad-GFP in the cytoplasm of the Y10A cells, but there seem to be a few such aggregates even in *foscrb* animals and large numbers of such aggregates in the Y10F animals (i.e., numbers comparable to those seen in the Y10A cells, see 3A\' and 3B\', respectively).

In the subsection "The FBM of Crb is essential for the morphogenesis of the AS", fifth paragraph, the authors state: \"Apoliner expression in the AS of *foscrb* and *foscrb~Y10F~* embryos ([Video 9](#media9){ref-type="other"}) revealed some apoptotic cells at the posterior canthus at the end of GB retraction ([Figure 4A, B](#fig4){ref-type="fig"}, arrows). In *foscrb~Y10A~* embryos of a similar age, some detached cells ([Figure 4C](#fig4){ref-type="fig"}, arrowheads) as well as those at the posterior edge of the remaining AS ([Figure 4C](#fig4){ref-type="fig"}, arrow) appear as apoptotic cells.\"

First, the authors miss a key paper on apoptosis in the amnioserosa (Shen et al. 2013 PLoS ONE 8:e60180), which presents data in form that is much easier to interpret (see Shen et al. [Figure 5](#fig5){ref-type="fig"}). To me, the data presented here suggest that despite substantial differences in AS morphology, that the level of apoptosis in Y10A animals is about the same as in *foscrb* and Y10F embryos (there may be some additional apoptosis at lesions in the AS). The authors go on to write \"At the end of DC, the internalised AS cells are localised in a central rod-like structure in *foscrb* and foscrbY10F embryos and subsequently die by apoptosis ([Figure 4D, E](#fig4){ref-type="fig"}) \[as has been reported for wild type embryos (Reed et al., 2004)\], while in *foscrb~Y10A~* embryos of similar age, the remaining AS cells have completely disaggregated ([Figure 4F](#fig4){ref-type="fig"}).\" What do they authors mean by \"a similar age\"? To me this is completely consistent with the interpretation that morphogenesis is delayed and the programed cell death of the AS occurs \"normally\" in the animals with all three *foscrb* variants. The authors go on to state \"To summarise, the AS in *foscrb~Y10A~* embryos breaks apart and undergoes premature apoptosis\". I agree that the AS breaks apart, but it is not clear from the data as described that the apoptosis is \"premature\".

They next write \"suggesting that an intact FBM is required for maintaining the elasticity of the AS\". There is nothing in this paper that evaluates the \"elasticity\" of the AS. Again, they need to know that *crb* is folding properly to draw conclusions about a defective FBM (vs. a key role for crb) and they can at best replace \"elasticity\" with \"integrity\".

*Reviewer 4:*

We know from previous work that the Crumbs FERM domain-binding motif (FBM) directly interacts with the FERM-domain of Yurt (Yrt) and Expanded (Ex) and recruits Moesin to the apical membrane. And we know that mutation of this domain has no effect on the many other tissues where Crumbs has a role, but has lethal phenotype in the embryo, which this study shows to be due to an overactive actomyosin network. The live-imaging of Cadherins using *D*E-cad::GFP knock-in allele in a *crb* null background with formed introduced variants of crumbs is well-executed, systematic and key part of the study from which the conclusions are derived. The authors cleanly demonstrate a Yrt independent role and then show that *foscrb~Y10A~* show defects in the establishment of the actomyosin apparatus cells in a situation where components of the Zonula Adherens are disturb or missing. Next the authors go on to show that the FBM of Crb is an important regulator of cytoskeletal activity and cell-cell adhesion of the amnioserosa and required for its proper morphogenesis. The next set of experiments are the \'meat\' of the paper and they comprehensively address the role of Crumbs FBM in actomyosin dynamics and show that the FBM of Crb regulates actomyosin dynamics in the amnioserosa during dorsal closure by down-regulating the Rho1 pathway. Finally the authors show that the dorsal-closure phenotype of CrbY~10A~ embryos also due to reduced adhesion. The authors have carefully dissected out Crumb function through the FBM. As they point out we do not yet know if the actomyosin phenotype and the reduced adhesion ones are linked or not. The phenotypes could result from defects in amnioserosa differentiation or in its attachment to the basal lamina. The authors raise this point themselves and have \'data not shown\' to negate such conclusions. It will be good to see this data. While the work convincingly demonstrates a novel function of the FBM in cytoskeleton dynamics and also show that Crb regulation of amnioserosa morphogenesis involves *D*Moesin, Rho- GTPases, class-I Pak, and the SCAR-Arp2/3 complex, two questions remain. How does this regulation take place (three ways are suggested) and why other epithelia which require Crumbs does not seem to require this domain (while requiring the downstream partners). The key question then is whether the role of the FBM show is a peculiarity that details out an aspect of Crumbs or if it is telling us something broader about its role in epithelial morphogenesis. It will be good to see a discussion on this.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Crumbs is an essential regulator of cytoskeletal dynamics and cell-cell adhesion during dorsal closure in *Drosophila*\" for further consideration at *eLife*. Your revised article has been favorably evaluated by K VijayRaghavan (Senior editor, who also served as Reviewing editor) and three reviewers. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

The reviewer reports are appended below. The authors will see that all the issues, but one, are readily addressed by editing the text. Reviewer 3\'s first comment is an important one, which is speedily addressable experimentally. *eLife* usually does not ask for multiple rounds of experiments but we were not convinced by the rebuttal in this case, and need to be assured with a micrograph of quality that the interpretation presented is valid.

*Reviewer 1::*

In their revised manuscript, the authors have included new data and analyses, and have clarified the text to adequately address most of the considerable reviewers\' comments. While some of the mechanistic questions raised are still unanswered, in particular in the sections relating to the role of Rho GTPases, the authors did try to address these with the available reagents. The overall flow of the paper is much improved.

*Reviewer 2:*

I think this new version of the manuscript has very much improved. The text and figures have been simplified which benefits the delivery of the main message. I also think the Discussion better integrates different interpretations of the cause of the phenotype, both at the level of the tissue contributions (dorsal epidermis and AS) and of the cellular processes involved (actomyosin contractility and cell-cell adhesion).

More specific issues:

I particularly like [Figure 7--figure supplement 1](#fig7s1){ref-type="fig"} more than new [Figure 7. I](#fig7){ref-type="fig"} find the genotypes are easier to follow and think the subtleties of the DC defects are important. The addition of error bars is a good idea but in this case I would also add statistical significance of the differences observed.

I suggest Figure 5--figure supplement 2 goes to the main text: it\'s a very important piece of data and captures very nicely the behaviour of actomyosin foci.

*Reviewer 3:*

This is a vastly improved manuscript that is now nearly ready for publication in *eLife*.

I still have 6 concerns that should be corrected before publication.

The authors assert that Baz is retained at the leading edge of Y10A embryos. The micrograph they present in 2J is simply not compelling and the rebuttal they provide is simply not convincing. If Baz is preserved at the leading edge in Y10A embryos surely a micrograph that provides more compelling evidence should be easy to obtain? Compare their localization of Baz in wild type to that presented by Laplante and Nilson, 2011, which they cite.

[Figure 2M and N](#fig2){ref-type="fig"} show schematics to help the reader figure out what the main features of the Y10A phenotypes are. There is little or no evidence for the presence of a conventional myosin in filopodia. Interestingly, although the Sas data show filopodia, neither the actin nor the myosin panels show filopodia very well (there seem to be some filopodia in the actin panel E). The schematic that shows \"actomyosin\" should be removed. Actin might be shown in filopodia the actomyosin cable, myosin should be shown only in the actomyosin cable.

Gorfinkiel and Martinez-Arias (2007) showed that while Cadherin is initially localized to the leading edge of the DME cells, that it is cleared with time. In my first review, I was afraid that the phenotype shown for loss of cadherin in Y10A animals was due to the normal clearing of cadherin from the leading edge later in closure. The authors provide a convincing rebuttal that they are comparing early stage *foscrb* animals to early stage Y10A animals. They should simply add a sentence to the revised manuscript to indicate that they know that cadherin is cleared at later stages and that this comparison is between different genotypes during early closure stages. The readers need to know this as much as do the reviewers.

While pulsing or oscillating amnioserosa cells characterize dorsal closure in wild type embryos and are very interesting, it is not clear to me that oscillations \"are required\" for closure. Thus, oscillations can be suppressed and closure still occurs. The sentence that begins "Besides elongation of the DME cells and integrity of the AS, DC requires pulsed contractions of the AS cells..." should be revised.

[Figure 6G](#fig6){ref-type="fig"} is referenced as a model for how the FDB of Crb might regulate cytoskeletal function. I am puzzled by some of the details. In particular, the model has Rok and *D*Pak as positive regulators of MLCK. My understanding is that MLCK, Rok and *D*Pak all phosphorylate sqh directly, so arrows from Rok and Pak to MLCK and not to sqh are at best misleading and more likely simply wrong (unless there are data in the literature that I simply don\'t know about). Second, Rok has an inhibitory connection to flapwing. Is that really the case? Does Rok phosphorylate Flapwing to inhibit its phosphatase activity or otherwise bind to Flapwing to sequester its activity?

10.7554/eLife.07398.050

Author response

*Overview of referee comments: The reviewers agree that that this is potentially good work and in revised form could be of interest to a large audience. For a substantially revised manuscript to make a valuable contribution to* eLife *there are several major issues, including important controls that need to be addressed. The authors need to improve the delivery if they want this paper to have the impact they want it to have. As presented, it is difficult to read and experimentally incomplete. Part of the problem is that paragraphs are not very well structured and topic sentences don\'t adequately describe the topics addressed in the paragraph. Thus the reader is expecting to learn about one thing but data and details are presented regarding many others. Part of the problem may also be that the authors have presented a lot of material (too much material?) and as a consequence, the presentation is not as clear or complete as it might be. There are in addition some technical problems with the data as presented. The authors should focus on presenting their findings more clearly and more completely, potentially removing some findings in order to better document and provide appropriate controls on other findings.* We substantially modified the text and thus improved clarity. In addition, we removed some of the data (or present them as supplementary material). For example, the Y10F variant was used as a control to show that mutating the Y10 is not, by itself, destructive and that the defects in the Y10A variant are due to a conformational defect rather than a putative phosphorylation defect. Indeed, it was shown recently by Wei et al., (J Biol Chem 2015 290:11384) that the Y10A mutation in the FBM of Crb ablates the interaction with Moesin. We removed all results from the Y10F variant from the main figures, and added them as complementary when necessary. Also, we removed all the movies with the results of the Y10F variant. We modified the text accordingly, to improve the flow of the text.

*The domain-specific phenotypes are the major thrust of the paper. Therefore the authors must with clarity establish that the phenotypes are due to the mutant domain (the authors still need to verify that the protein is properly folded and trafficked to conclude that the phenotypes are domain- and not simply crb- specific). Better showing the localization of the mutant protein at higher resolution and in all tissues would be valuable. Presumably, in tissues that are unaffected, it should look precisely like the wild type or the Y10F variant.*

The localisation of the different *foscrb* variants in different tissues has been documented in our previous work Klose et al., 2013 (G3 2013, 3:153). Nonetheless, in the first paragraph of the Results section we stress that the fosCrb~Y10A~ protein localises apically in most embryonic epithelia, which also appear to have normal cell polarity (like the epidermis, for example). Besides this, in our current manuscript you can see the localisation of Crb and Crb~Y10A~ in the embryonic epidermis (previously [Figure 1J, K, L](#fig1){ref-type="fig"}; now [Figure 1I, J](#fig1){ref-type="fig"}). The localisation of all these variants in the amnioserosa is very difficult to obtain in fixed samples, because it appears to be highly dynamic according to our observations with a *fosCrb::EGPF* version (D.F.B and E.K. unpublished observations).

*Having done this, the authors need to carefully discuss direct- and indirect- phenotypes, making sure that they are not over-interpreted. The rescue experiments with Rho and Flw suggest that there could be a more direct effect on actomyosin activity on top of the adhesion defects. In this context it is important that the major conclusion that Crumbs is negatively regulating Rho1 should be tested directly (see specific comments below). The \"meat\" of the manuscript lies on the set of rescue experiments of dorsal closure, and particularly of amnioserosa morphogenesis. However, the authors make the analysis of the defects at the level of dorsal epidermal cells an important part of the work which then seems to be set aside. The inclusion of the section describing AS cells becoming migratory is not salient to the authors\' major points, but is a bold statement with the data presented. They should remove this section from the paper or provide additional control experiments to show these cells are not escaping hemocytes.*

We re-wrote some parts of the Discussion and carefully took the possibility into account that some of the observed defects are an indirect consequence of the over- contraction of the AS in the *foscrb~Y10A~* embryos (second and third paragraphs). Regarding the direct measurement of Rho1, we explain the reasons why this experiment is not feasible (see below). About the AS cells becoming migratory, we moved the scanning EM data into the supplement (now [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}) and toned down the conclusion as recommended by the Reviewer 1 in point \#3 (see below) (subsection "The FBM of Crb is essential for adhesion of the AS", third paragraph).

Specific Comments:

Reviewer 1:

*This paper provides convincing phenotypic evidence for the crumbs allele* foscrb~Y10A~ *causing defects to the DME supracellular actin cable, DME protrusions, and amnioserosa over contractions. However, a major concern is that there is little evidence that all of these strikingly documented phenotypes are not secondary to the adhesion defects found here and expected in a crumbs allele. As such, some of the conclusions are overstatements of the data presented.*

We re-wrote several of the conclusions and we have tried to be more sober and moderate in the statements. Nevertheless, regarding the adhesion defects observed in the *foscrb~Y10A~* embryos, those are not similar to the phenotypes described for *crb* loss of function, because i) theY10A phenotype is very specific to the AS, and ii) it develops later, and iii) it depends on the FBM. Take, for example, the fact that, the expression of *UAS-Pak-AID* with the GAL4^334.3^ is enough to rescue the lethality of the *foscrb~Y10A~* embryos, leading to adults that do not show any major or obvious defects in other tissues ([Figure 7D](#fig7){ref-type="fig"}). This supports the conclusion that the *foscrb~Y10A~* allele is not alike to the well-documented loss-of-function *crb* alleles characterised in this and other labs. Whether some of the documented phenotypes are or are not secondary to the adhesion defects, are now discussed and we agree that is a conundrum to be solved (subsection "The FBM of Crb controls actomyosin dynamics in the AS", sixth paragraph).

*1) While the images and movies provided are often striking, quantification would be helpful especially in DME phenotypes. For instance, in Figure 20 the authors highlight cells, which masks the ability to judge expression independently; a line profile across these cells and adjacent cells would helpful.*

Done. We now show the image without the highlight ([Figure 2J](#fig2){ref-type="fig"}) and complemented it with the line profile along the DME cells using the signal from phosphotyrosine staining as a reference for the ZA. In the [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"}, we show that Bazooka intensity in the DME cells is strongly reduced in the *foscrb~Y10A~* embryos.

*Similarly, the differences in cadherin clustering in [Figure 3A-F](#fig3){ref-type="fig"} are hard to gauge in the picture shown and would benefit from quantification.*

We provide better quality images of the AS at stage 11 ([Figure 3](#fig3){ref-type="fig"}). In those images it is possible to see the disruption in *D*E-cad continuity at the ZA of *foscrb~Y10A~* embryos ([Figure 3E](#fig3){ref-type="fig"}). Moreover, because we now employed a *D*E-cad::mTomato knock-in allele (viable knock-in allele -- Huang et al,. 2009 PNAS 106:8284-- like the *D*E-cad::GFP allele used in the rest of the work), the auto-fluorescence from the yolk is very low, improving the signal-to-noise ratio. However, the quantification of those defects appeared to be quite arbitrary. Of course it is possible to gauge the intensity of *D*E-cad along the ZA in both *foscrb* and *foscrb~Y10F~* embryos (for example with a line profile). On the contrary, in *foscrb~Y10A~* embryos, the positioning of the line (i.e. ROI) along the ZA in the AS becomes arbitrary, as the signal is not continuous or even lost, so we are not absolutely confident of drawing the ROI along the ZA. This is even more problematic at later stages, when the ZA becomes extremely disrupted (see current [Figure 5B](#fig5){ref-type="fig"}).

*2) The conclusion that Yurt is uninvolved because its phenotype is qualitatively less severe could be explained by it only being involved in a subset of activities. Combining* foscrb~Y10A~ *with a yurt allele could easily test this possibility.*

The experiment and the video were already presented in the first version of the manuscript ([Video 4](#media4){ref-type="other"}), now ([Video 7](#media7){ref-type="other"}). We now also explain in more detail the Yrt phenotype and change the referred paragraph to make clear that the *yrt* phenotype is different from the *foscrb~Y10A~* mutant, and also that there is no enhancement or suppression of the *foscrb~Y10A~* phenotype when combined with the zygotic *yrt* mutant (subsection "The FBM of Crb is essential for the integrity of the AS", third paragraph). The *foscrb~Y10F~* embryo was removed from the movie, because it is phenotypically identical to the *foscrb* when combined with the *yrt* mutant.

*3) The finding that amnioserosa cells are becoming motile is very striking. However, these cells resemble hemocytes, especially in the SEM pictures. If the amnioserosa has holes in it, as well as prematurely apoptotic cells, it would be expected for hemocytes to be responding to clear this cellular debris. The authors should confirm that the mobile cells are not hemocytes or tone down this section.*

Done, we toned down the conclusion and stated that we do not know the identity of these migratory cells, which can well be haemocytes escaping through the hole in the AS of the *foscrb~Y10A~* embryos (subsection "The FBM of Crb is essential for adhesion of the AS", third paragraph).

*4) The major conclusion that Crumbs is negatively regulating Rho1 should be tested directly, especially considering some of the surprising results in the rescue experiments where Rok, loss of function Rho1 and Rho1 dominant negative alleles do not give similar results. Is Rho1 or active Rho1 increased in the* foscrb~Y10A~*background?*

Because this is one of the major points in the manuscript, we obviously wanted to know the precise change on Rho1 activity. Also, because the use of dominant negative or dominant active constructs can mask the effects of other small GTPases, we wanted to analyse the in vivo condition. Nevertheless, it is not possible to measure active Rho levels by conventional assays (like the Pull-down Activation Assay): the AS represents a very small proportion of the whole embryo, and even in the case that all the Rho protein is active (i.e. GTP loaded) in the AS of the *foscrb~Y10A~* embryos, we think that the other tissues of the embryo will mask the difference when processed for the assay.

However, we tried to approach this question by other strategies. First, we used the available lines that express Rho1::GFP under the control of the Rho1 promoter created in the lab of Susan Parkhurst, but none of them was strong enough and the signal-to-noise ratio was too low for analysis. We tried to generate recombinant stocks with the *Rho1^1b^* allele plus the Rho1::Rho1::GFP construct, plus the corresponding fosmid, plus the *crb* null allele (i.e. *w\*; foscrb,Rho1^1b^,Rho1::Rho1::GFP/CyO, twi::GFP;crb^GX24^/TM3, twi::GFP*), but this approach was unsuccessful, as the intermediate stocks were very weak.

Another strategy consisted in the use of Rho family GTPase activity biosensors also generated by the Parkhurst lab (though they have not been characterised completely). Some of them are expressed constitutively and others are UAS constructs. We explored the use of different Rok^RBD^, Dia^RBD^, Capu^RBD^ and Pkn^RBD^ versions with different GAL4 drivers, too, and none of them gave a useful signal-to-noise ratio in our imaging settings. A new probe was reported by the Lecuit lab (Anillin::GFP, Munjal et al., (2015). Nature, DOI: 10.1038/nature14603), but the work was published on 27 July, so for obvious reasons we have not tested this probe.

Reviewer 2:

*This is a compelling, interesting and rigorously crafted work that reports novel and important information that will be of interest to a large audience. I enjoyed very much reading this work which opens up several research avenues to unravel the molecular mechanisms underlying amnioserosa cell apical contraction. I only have a couple of questions: 1) The authors say that Crumbs is a negative regulator of actomyosin dynamics and report an increase in the number of myosin (Zipper) foci, which persist longer and are more disorganized. I wonder if actin localization also follows this aberrant dynamics. It is very likely that it does so, but it may be good to check.*

We generated flies where the *D*E-cad::mTomato allele was recombined with the actin binding domain of Utrophin tagged with GFP and expressed under the control of the spaghetti squash promoter (sqh::Ut::GFP), and put in the *crb* null background. We have not analysed these embryos in detail. We provide a video ([Author response video 1](#respmedia1){ref-type="other"}), where it is possible to appreciate the pulsed contractions in a *foscrb* embryo, and that the AS of the *foscrb~Y10A~* embryo is strongly disrupted (inside the dotted line in the merge of the *foscrb~Y10A~* embryo). The *D*E-cad::mTomato is disrupted in the "left over" of the AS, but nevertheless, it is possible to appreciate in the green channel clusters that resemble the ones observed with Zipper. Since this result is somewhat redundant, we mention it as "data not shown "in the text (subsection "The FBM of Crb controls actomyosin dynamics in the AS", first paragraph).Author response Video 1.Dorsal closure (DC) in a *w;foscrb,DE-cad::GFP;crb^GX24^* embryo.Note that the granules from the yolk are visible because of their strong auto-fluorescence in the green part of the spectrum. Time-lapse: 3.5 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.044](10.7554/eLife.07398.044)10.7554/eLife.07398.044

*2) Regarding the defects of epidermal cells that are in contact with the amnioserosa and the disorganization of the actin cable and filopodia in foscrbY10A embryos, the authors seem to favor the idea that they are a secondary effect due to defects in the contraction of the amnioserosa. Although I agree that some of the observed defects can be attributed to a failure in amnioserosa morphogenesis (i.e.* D*E-Cadherin localization), I think that some of the defects could be due to a specific function of Crumbs in these cells. In this sense, I wonder whether the authors have observed any differences in the organization of the dorsal epidermis in the different rescue experiments performed, i.e. is the actin cable, filopodia formation or Ena localization differentially restored when Flw is ectopically expressed in the AS or when one copy of* SCAR, Arp3 *or* Arpc1 *is removed from foscrbY10A embryos?*

Indeed, we have not explored in detail the organisation of the DME cells in the different rescue experiments. We have made some observations that support the idea of a secondary effect: the elongation of the DME cells is restored in *foscrb~Y10A~* embryos expressing Pak-AID only in the AS. This was observed using *D*E-cad::GFP in a heterozygous combination, so the signal-to-noise ratio is not the optimal to show it. In [Author response video 2](#respmedia2){ref-type="other"}, the upper panels show the max projections of the stacks obtained. As *D*E-cad::GFP is heterozygous, the contrast is very low. In the lower panels, part of the same stacks was used to remove the autofluorescence from the yolk and the vitelline in Fiji.Author response Video 2.Dorsal closure (DC) in a *w;foscrb,DE-cad::GFP;crb^GX24^* embryo.Note that the granules from the yolk are visible because of their strong auto-fluorescence in the green part of the spectrum. Time-lapse: 3.5 min; 12 fps.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.045](10.7554/eLife.07398.045)10.7554/eLife.07398.045

Thus, to obtain a reasonable number of observations and analyse these defects in detail, we need to generate other stocks in which the *DE-cad::mTomato* allele is recombined with the appropriate genotypes. However, we have not analysed the cytoskeleton dynamics of the DME cells in these conditions, so we cannot exclude the possibility that some of the defects in the DME cells of *foscrb~Y10A~* embryos are secondary to the defects in the AS. Accordingly, we discuss these aspects more carefully in the manuscript (Discussion, last paragraph).

On the other hand, in another set of unpublished experiments we used the engrailed-GAL4 or the patched-GAL4 drivers to express different constructs (*UAS-Ena::GFP, Uas-Pak-AID, UAS-Moesin, UAS-moesin^T559D^, UAS-flw*, etc.) in stripes on the epidermis of the *foscrb~Y10A~* embryos, but so far we did not find any suppression or rescue of the Y10A phenotype.

Reviewer 3:

*A substantially revised manuscript with some additional controls may well make an excellent contribution to* eLife. *1) A previous finding was that a fosmid covering the entire crumbs (*crb*) locus,* foscrb *or a variant that replaces a conserved tyrosine with phenylalanine (*foscrb~Y10F~*), but not alanine (*foscrb~Y10AI~*) could completely rescue the embryonic lethality, germband retraction, dorsal closure and head involution defects that characterize homozygous,* crb *null animals. They evaluate* crb *function in detail by analyzing* foscrb *and variant rescue of* crb *null specimens using live imaging of a knockin allele of* D*E-cadherin,* D*E-cadGFP. The* foscrb~Y10A~ *animals show major defects in germ band retraction, have a highly disorganized amnioserosa which is lost over time. Ultimately dorsal closure fails. The authors do not make clear why they have chosen to analyze two variants, Y10F, which in all cases mimics the wild type Y10 variant and Y10A, which in all cases behaves quite differently. They should explain why they are evaluating Y10F and might save considerable space by simply reporting that the Y10F variant behaves like the wild type Y10 in all cases (perhaps I missed where it did not?).*

Thanks for the suggestion. We now explain in the first paragraph of the Results that the *foscrb~Y10F~* allele is a control, in which embryonic development occurs as in *foscrb* or wild type embryos. We also explain that these results indicate that the phenotypes in *foscrb~Y10A~* embryos are due to the conformational distortion of the FERM-domain binding motif of Crb (as recently shown by Wei et al., 2015 J Biol Chem 290:11384), and not because of a putative interference with the phosphorylation of Crb in this tyrosine residue. Accordingly, we decided to remove all the results from the *foscrb~Y10F~* variant from the main figures and videos, and added them as figure supplements when we considered necessary, which not only saves space, but also improves the flow of reading.

*2) Next, they examine a role for Yrt, a candidate FERM domain protein that may act in concert with Crb. Normally, Crb,* D*Patj and Yrt are expressed at higher levels in the epidermis than the amnioserosa, but are largely absent from the leading edge of the dorsal most cells. In the Y10A animals, the DMEs fail to elongate properly and Crb and* D*Patj are associated with the leading edge, particularly in cells that remain short. In contrast, Yurt is absent from the leading edge in normal and Y10A animals. In addition, the authors find that the* yrt *mutant phenotype is different than the Y10A mutant phenotype, which they state starts earlier and is more complex than the* yrt *phenotype. They conclude the* yrt *seems not to be involved with the phenotype of Y10A embryos (this is not convincing, see specific comments below).*

We have addressed these issues (please see below).

*3) Next the authors demonstrate that a key feature of the Y10A phenotype is the absence of filopodia at the leading edge and conclude that* crb *function is required for normal microvilli. 4) The authors then turn their attention to how* crb *functions in the localization of echinoid and the formation of the actomyosin rich cable in the DME cells. They describe changes in echinoid distribution and report alterations in Baz distribution that are not particularly convincing. In addition they found that yrt, coracle and Dlg distributions were normal in all fosmid variants and conclude that* crb *is not responsible for specifying their localization.*

As Reviewer 1 also pointed out, the defects in Bazooka distribution in the DME cells of *foscrb~Y10A~* embryos were not clear, and according to his request, we now show the image without the highlight ([Figure 2J](#fig2){ref-type="fig"}) and complemented it with the line profile along the cells using the signal from phosphotyrosine staining as a reference for the ZA. In the [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"}, it is possible to see that the Bazooka intensity in the DME cells is strongly reduced in the *foscrb~Y10A~* embryos.

*5) Next, the authors evaluate* D*E-cadherin localization in the* foscrb *variants and report that in* foscrb *and Y10F* D*E-cad localizes at all cell-cell contacts, including at the LE, but fail to discuss the normal loss of* D*E-cad from the leading edge later in closure. Have they evaluated DE-cad distributions throughout closure (it changes dramatically)? The authors report that DE-cad at the LE and in the amnioserosa is reduced it the Y10A animals. Their conclusion that Y10A animals lack the actomyosin apparatus of the LE is certainly justifiable, but they should refine their conclusions about adhesion based on better characterization of the* D*E-cad distributions at early and late stages of closure.*

This question also refers to your specific comment below regarding the normal loss of *D*E-cad from the leading edge, we refer to [Figure 1](#fig1){ref-type="fig"} from Gorfinkiel and Arias 2007 (J Cell Sci 120:3289), which shows a late stage of DC (during the zippering phase), which is, however, never reached by the *foscrb~Y10A~* embryos. Our characterisation focuses on earlier stages of embryonic development (i.e. form the start of germ band retraction), because these are the time points when the Y10A phenotype starts.

Anyway, in [Author response image 1](#fig9){ref-type="fig"} you can see that, at late closure, the loss of *D*E-cad from the LE indeed occurs in *foscrb* and *foscrb~Y10F~* embryos (see the arrowheads). These observations are consistent with our conclusions, as these alleles rescue the lack of endogenous *crb* completely, and behave, in all analysed aspects, as wild type.10.7554/eLife.07398.046Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.046](10.7554/eLife.07398.046)

Please note that we call the attention to defects in *D*E-cad localisation in the LE from the beginning of DC in *foscrb~Y10A~* embryos. Thus, we think that it is not necessary to include these observations into the manuscript as the redistribution of *D*E-cad at late stages does not change our interpretation about the defects in the AS of *foscrb~Y10A~* embryos.

*6) The authors also evaluate the state of the amnioserosa in Y10A mutants and report that there are discontinuities in the distribution of* D*E-cad on AS borders and that there are large intracellular clusters of* D*E-cad in the Y10 animals (however, see comments below). Because germband retraction fails in these embryos, it is not clear that the defects reported are due to defects in dorsal closure per se and the authors should rethink their conclusions as a consequence.*

This comment is about the same topic as comment \#7, so please refer to the answer below.

*7) Next the authors evaluate the integrity of the amnioserosa. They do not really explain why they used imaging of the microtubule binding protein Jupiter to do so (no comment on microtubule distribution or function is present, so the reader is left wondering). Nevertheless, they find that while extensions of the amnioserosa over the epidermis characterize all three variants of* foscrb, wt *and Y10F extensions are resolved during closure, but the in Y10A animals they are not. Again, a reasonable possibility seems to be that the amnioserosa is falling apart and because germ band retraction and dorsal closure have not progressed in Y10A animals that the AS cells take on the random migration phenotype. The SEMs presented confirm that aberrant nature of the apical surfaces of the AS cells that is consistent with their entering apoptosis. This may be because they are prematurely apoptotic or instead that they are undergoing apoptosis at an \"appropriate\" time, but germ band retraction and dorsal closure is delayed. Can the authors reference other developmental stages that confirm or refute this interpretation?*

We employed Jupiter::GFP as a probe to follow the morphogenesis of the whole embryo, because this marker 1) is expressed in all cells, 2) it is a Protein Trap, so its 3) expression is under the control of the endogenous promoter, 4) it is homozygous viable, and 5) no phenotype has been reported for this allele. This offers an advantage over other available markers, like the actin-binding-domain of Moesin::GFP, which is expressed under the control of the *sqh* promoter or UAS, or LifeAct, which was not suitable in our experiments. For more clarity, we have removed the Jupiter::GFP experiment completely.

On the other hand, we also thought about the possibility of a "delayed" germ band retraction in *foscrb~Y10A~* embryos, but conclude that AS apoptosis occurring at the "appropriate" time is very unlikely. For example, expressing flapwing or Pak-AID in the AS is enough to suppress the germ band retraction phenotype, which suggests that this phenotype is secondary to the defects in the AS.

Unfortunately, we cannot use other morphological characteristics, such as the elongation of the hindgut, or the branching and fusion of the tracheal system, because these characteristics are disrupted in the *foscrb~Y10A~* embryos, probably due to defects in germ band retraction (this work and Klose et al., 2013 G3, 3:153).

We are aware of the difficulty in staging *foscrb~Y10A~* embryos (and other mutant genotypes) (Klose et al., 2013 G3, 3:153). Thus, as we did in the previous work and as it is now explained in the current Results (subsection "The FBM of Crb is essential for dorsal closure") and Material and methods (subsection "Embryo collection and antibody staining"), all genotypes are collected *at the same moment* and collections are limited to a short period of time (specified in each figure or movie). Then, the embryos are incubated the appropriate time and fixed or imaged *at the same time* (even in live imaging, the three genotypes are *in the same chamber* and imaged using a multiposition setting), and the stage refers to the *foscrb* morphology based on Campos-Ortega and Hartenstein 1985 (The Embryonic Development of *Drosophila melanogaster*). Accordingly, when we describe any defect in the *foscrb~Y10A~* embryos, we always compare it to the *foscrb* embryos of the same age, meaning that both have been analysed at the same time after egg collection.

Consequently, for example, if we report a defect in germ band retraction (take for instance [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}), it is because at this time point, the *foscrb* and the *foscrb~Y10F~* embryos (the control embryos) already finished retraction.

To disentangle whether the defects in the germ band are a direct or indirect consequence of the DC defects is something beyond the aim of our present work. This specific topic has been analysed by others, so the roles of the AS (mechanical and/or biochemical) during germ band retraction are still under intense research: Yip et al., 1997 Development 124:2129; Lamka and Lipshitz, 1999 Dev Biol 214:102; Schöck and Perrimon, 2002 Dev Biol 248:29; Schöck and Perrimon, 2003 Genes Dev 17:597; Kozlova and Thummel, 2003 Science 301:1911; Reed et al., 2004 Curr Biol 14:372; Zúñiga et al., 2009 BMC Biol 7:61; Lynch et al., 2013 Dev Biol 384;205; Lynch et al., 2014 New J Phys 16:055003.

*8) They next evaluate apoptosis and conclude that apoptosis is premature in Y10A embryos. For reasons detailed below, their data are not convincing on this point.*

We guess you are referring to our statement \"Apoliner expression in the AS \[...\] appear as apoptotic cells\" as "reasons detailed below", so please read the following response.

*9) They also evaluate JNK signaling using* puc-LacZ *which is a biomarker for JNK signaling. They show convincingly that* puc-LacZ *localization is aberrant in Y10A embryos, most likely as a consequence of the abnormal elongation of DME cells. However, because there is the same number of* puc-lacZ *positive nuclei in the Y10A animals, the authors appear to conclude that JNK signaling is normal. Nevertheless, they never explicitly say that JNK signaling is normal in the Y10A embryos.*

Done; the conclusion has been included (subsection "The FBM of Crb is essential for the integrity of the AS", end of fifth paragraph).

*10) The authors go onto evaluate pulsed contractions of the amnioserosa cells. Videos and stills confirm that the individual cells in Y10A embryos are hard to discern. Nevertheless, there are pulsed contractions that are occurring in* D*E-cad labeled embryos. In addition, the zipGFP labeled embryos show clear, pulsed formation of myosin foci that subsequently disperse. The authors note that the period of the formation and dispersal of foci is very irregular in the Y10A embryos and the movies and kymographs are consistent with that observation. However, such movies and kymographs (of selected foci) do not give a sufficiently quantitative overview of the effect. The authors should quantify periods for randomly chosen foci in the wt, Y10F and Y10A cells. At least tens of foci should be analyzed, if not a hundred or so. Histograms of observed periods for foci formation and dissolution would be essential for drawing the conclusions that they subsequently draw as to the role of* crb *FBM in regulating actomyosin.*

Done; the histograms confirm our observations (see Figure 5--figure supplement 3).

*11) The authors show that over expression of Flapwing, a phosphatase for phospho-sqh suppresses the Y10A failure in germ band retraction and dorsal closure. This is a very interesting finding and provides the most compelling evidence that* crb *mediates its effects through regulation of myosin contractility. Nevertheless, it is somewhat surprising that the authors did not evaluate better the effects of flapwing expression on the integrity of the amnioserosa cells (as assayed in* D*E-cad-GFP expressing embryos). Thus, [Figure 5](#fig5){ref-type="fig"} panels M-O are at very low magnification and quality such that the integrity of the AS cells and the* D*E-cad-GFP adhesion junctions cannot be ascertained. The authors should present movies comparable to [Video 10](#media10){ref-type="other"} with flapwing over expression and should also evaluate quantitatively the period of pulsed contractions in the flapwing over expressing embryos (for wt, Y10F and Y10A embryos).*

We could not evaluate the integrity of the ZA in vivo in experimental conditions where flapwing is expressed, because the *D*E-cad::GFP is heterozygous (recombined on the same chromosome as *UAS-flw*), so the signal-to-noise ratio is very low.

In the movie the reviewer is referring to (previous [Video 10](#media10){ref-type="other"}, now [Video 8](#media8){ref-type="other"}), the *D*E-cad::GFP allele was recombined with the corresponding *foscrb* variant, so it is homozygous and the signal to noise ratio is enough for a detailed observation of the *D*E-cad::GFP, despite the strong auto-fluorescence of the yolk. Hence, to make a proper analysis of the ZA in vivo when flw is expressed in the AS, the *D*E-cad::GFP allele should be recombined also on the chromosome carrying the corresponding *foscrb* variant and the GAL4^332.3^ (i.e. analysis of the embryo with the genotype *w\*;foscrb,DE-cad::GFP,GAL4^332.2^/UAS-flw-HA,DE-cad::GFP;crb^GX24^/crb^11A22^,UAS-Actin::RFP*), which was not feasible. Another strategy will be to recombine the *D*E-cad::mTomato with the *UAS-flw*, but these stocks were not ready on time for these experiments.

Nevertheless, we prepared movies (now [Video 12](#media12){ref-type="other"}, subsection "The FBM of Crb controls actomyosin dynamics in the AS") with better resolution of the AS in embryos expressing flapwing and heterozygous for *D*E-cad::GFP, where it is possible to appreciate the restoration of the *D*E-cad::GFP at the ZA in the AS of *foscrb~Y10A~* embryos. Regarding your last point, the analysis of the period of pulsed contractions, the low signal-to-noise ratio makes this analysis quite laborious and even arbitrary, as increased laser power lead to bleach and other technical problems (like cell-cell adhesions not really distinguishable).

Although it is reasonable to expect that the pulsed contractions will be damped by flapwing expression, this information is not related to the main aim of our work. Please bear in mind that this experiment is a "proof of principle", in which we asked whether the expression of the myosin phosphatase leads to a suppression of the DC phenotype of the *foscrb~Y10A~* embryos. Other approaches could have been the expression of the MBS (another subunit of the myosin phosphatase), for example. Thus, we don't see the justification to analyse the period of pulsed contractions (or other mechanical properties) of this tissue in these settings. As stated above, those analyses require the generation of other tools.

Nevertheless, we made very preliminary and crude analysis (2 embryos/genotype) and the DC rate after expression of Flw seems to be unaffected in *foscrb* embryos and normal in *foscrb~Y10A~* embryos ([Author response image 2](#fig2){ref-type="fig"}).

*12) To understand the mechanisms by which myosin is phosphorylated, the authors turn their attention to three effectors of small GTPases in the Rho/Rac/Cdc42 family, Rok,* D*Pakand Scar. They present data in a table that is part of [Figure 6](#fig6){ref-type="fig"}. It is not easy to follow is only poorly referenced in the text. First, there are no error bars on the numbers presented. 71.3% or 70.5% really different than one another (probably not)? Are they different from 59.7 or 56.5 (without error bars, not possible to know)? My interpretation of the first 3 rows of the table is that the expression of* UAS-Actin-RFP*, under the control of an amnioserosal driver (I shouldn\'t have to reference another table to figure out where Gal4-332.2 is expressed) substantially suppresses the most severe dorsal open phenotype (i.e., from 59.7 to 18.5), but the authors don\'t comment on that. Perhaps they want us only to focus on the penetrance of the wt-like phenotype? If so they should explicitly say so and they should consider pooling the defects into a single dorsal open category, perhaps relegating the more detailed panel to supplementary material). Moreover, where they do explicitly draw our attention to changes, the comparisons seem flawed. They ask us to compare row 4 to row 3 to show that* UAS-crb *expression increases the most severe dorsal hole, but the embryos in row 4 don\'t express* UAS-actin-RFP *and the expression of* UAS-actin-RFP *greatly affects the number of animals in the most severe category (compare row 3 to rows 1 and 2). Similarly, rows 9 and 10 are compared to 3, but 9 and 10 don\'t express* UAS-actin-RFP*. Similarly, are differences seen with* UAS-moe *(without actin) vs. UAS phosphomimetic moe (with actin) simply due to the expression of actin? If I understand [Figure 6](#fig6){ref-type="fig"} correctly, experiments are not being compared to appropriate controls.*

Thanks for the suggestion of pooling the defects into a single dorsal open category. We modified the main figure as such and provided the detail graph as supplement. We also included 3 more control crosses ([Figure 7](#fig7){ref-type="fig"} and [Figure 7--figure supplement 1](#fig1){ref-type="fig"}, Bars 3-5) to have appropriate comparisons. Expression of *UAS-Actin::RFP* does not suppress the *foscrb~Y10A~* phenotype (compare 3^rd^, 5^th^ and 6^th^ bars) Also, now the graphs present the mean ± SD, while before it presented the overall percentage of the pooled experiments. Finally, we explained in more detail the comparisons in the Results.

*13) Nevertheless, some of the data show intriguing trends. Over expression of the autoinhibitory domain of* D*Pak suppresses the DC phenotype of Y10A animals, whereas over expression of* D*Pak induces a DC phenotype in otherwise normal embryos. Is it correct that autoinhibition of* D*Pak is intra-molecular?*

No, it is inter-molecular. The inhibitory domain in complex with PAK1 is a dimer between the auto-inhibitory region and the kinase domains. If you're interested into the details of the interaction these papers describe it: Lei et al., 2002 Cell 102, 387--397 and Parrini et al., 2002 Mol Cell 9, 73--83. Also, these reviews may be of interest: Hofmann et al., 2004 J Cell Sci 117, 4343--4354; Zhao and Manser, 2005 Biochem J 386, 201--214; Kumar et al., 2006 Nat Rev Cancer 6, 459--471.

*If so isn\'t it surprising that the autoinhibitory domain is effective when presented as a separate protein? How overexpressed is the domain?*

By "How overexpressed is the domain?" do you mean that you want to know the abundance? If so, we think that any kind of measurement seems to be arbitrary. It will compare a "0" expression level (CTL) vs a GAL4-induced expression. Even if we see any signal in immunofluorescence or Western blot, it will only be informative of whether the Pak-AID is expressed or not.

*Other key data are the suppression of Y10A DC phenotypes by the overexpression of* D*E-Cad. 14) Subsequent analysis of the role of Arp2/3 is focused on Arp2/3\'s role in endocytosis and is interpreted vis-à-visthe endocytosis of* D*E-cad. Lamelipodia and filopodia are a key feature of both the leading edge and amnioserosal tissues and Arp2/3 may have key roles in their function independent of their role in endocytosis. Why do the authors attribute the effects of Arp2/3 solely on endocytosis?*

We include this possibility in the Discussion (third paragraph and subsection "Crb -- a regulator of ZA integrity via actomyosin dynamics?").

*15) Finally, the authors conclude that* crb *function impacts both actomyosin dynamics and adhesion, and that the two effects may be inter-related, but the title of their paper suggests only a role in regulation of actomyosin dynamics. It is not clear why this is appropriate. While they use the Discussion to argue their point, it seems that a revised Results text, with some experimental revision may alter the conclusions made in the Discussion substantially. At this point their title should be revised to more accurately reflect the firm conclusions made in the Results and leave the speculation in the Discussion clearly marked as such.*

The major conclusion did not change. However, we appreciate the reviewer's suggestion and modified the title.

*In addition to these general comments, I make the following specific points for the Introduction and part of the Results. I incorporated comparable specific comments into the more general comments above for the remainder of the results but found that detailed comments were becoming both too numerous and too complicated.*

*In the subsection "The FBM of Crb is essential for dorsal closure", first paragraph: The authors conclude the FERM binding domain of* crb *is responsible for the effects that they see because a point mutation (Y10A) in the FBD fails to rescue* crb *mutant function. Do they know that the alanine variant is made and correctly trafficked to the plasma membrane? If so, they should say how they know that and provide a reference. Otherwise conclusions regarding FBD function (vs.* crb *function as a whole) are erroneous.*

As explained above in your first comment, and explained in the first paragraph of the Results, this was presented in our previous work: Klose, S., Flores-Benitez, D., Riedel, F., and Knust, E. (2013). Fosmid-based structure-function analysis reveals functionally distinct domains in the cytoplasmic domain of Drosophila crumbs. G3 (Bethesda) 3, 153--165.

*Certainly dorsal closure fails in these Y10A animals ([Figure 1C-I](#fig1){ref-type="fig"}), but germ band retraction is far from complete. Moreover, in normal embryos, the amnioserosa undergoes apoptosis upon completion of closure. Are the defects in closure observed due to the fact that at the posterior end the canthus does not form properly because of the incompletely retracted germ band and because the amnioserosa undergoes apoptosis thereby blocking closure? This puts a different spin on the defects observed.*

This is the same question raised in your comments 6 and 7; please see the corresponding responses.

*In the subsection "The FBM of Crb is essential for dorsal closure", the authors state that \"Of these protein species, Yrt appeared as a likely candidate responsible for the defects in the* foscrb~Y10A~ *mutant, since Yrt negatively regulates Crb (Laprise et al., 2006), zygotic* yrt *mutant embryos show DC defects (Hoover and Bryant, 2002), and over-expression of Crb in the amnioserosa results in DC defects (Harden et al., 2002; Wodarz et al., 1995)". I don\'t understand how \"over-expression of Crb in the amnioserosa results in DC defects\" makes Yrt a likely candidate? The manuscript is characterized by a number of statements such as this one that distracts the reader and detracts from the message that the authors are trying to deliver.*

We rephrased the third paragraph to make it clearer (subsection "The FBM of Crb is essential for the integrity of the AS"). The idea is that Yrt negatively regulates Crb by interacting with its FBM directly, and *yrt* mutants (which leads to Crb over expression) or *UAS-Crb* over-expression in the AS produces similar DC defects. Thus, it was possible that the interaction of Yrt and Crb is affected in the *foscrb~Y10A~* embryos. The epistasis analysis shows that this possibility is unlikely ([Video 7](#media7){ref-type="other"}).

*In the subsection "The FBM of Crb is essential for dorsal closure", fifth paragraph: The authors should show on the schematic in [Figure 1](#fig1){ref-type="fig"} the orientation of the cross sections shown in [Figure 1](#fig1){ref-type="fig"} panels M, N and O. Neither the text, nor the figure legend adequately describes the orientation of the section, and how it was obtained. Thus it is hard for the reader to understand what these panels are trying to show.*

We added a reference axis in [Figures 1J, K](#fig1){ref-type="fig"} and [Figure 4--figure supplement 3](#fig4s3){ref-type="fig"}, as well as the corresponding explanatory text in the figure legends.

*In the subsection "The FBM of Crb is essential for dorsal closure", the authors state: \"Moreover, in* foscrb *and* foscrb~Y10F~ *lacking zygotic* yrt *DC fails only after GB retraction, which is qualitatively different from the phenotype of* foscrb~Y10A~ *or* foscrb~Y10A~ *embryos lacking zygotic* yrt *([Video 4](#media4){ref-type="other"})\". The authors should state explicitly how the phenotypes are qualitatively different and explicitly state whether or not the Y10A phenotype differs in the presence or absence of zygotic* yrt*. In addition the next sentence \"These results suggest that the DC phenotype of* foscrb~Y10A~ *embryos starts earlier and is more complex than that in* yrt *mutants\" requires the authors to give us more details about the* yrt *phenotypes, which are only referenced and not adequately described. I found this paragraph very hard to get through. The authors should consider reworking it for clarity.*

Done, see subsection "The FBM of Crb is essential for the integrity of the AS", third paragraph.

*In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", first paragraph: The authors should provide a reference or other explanation of why Sas stains filopodia.*

This has been moved to the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable in the DME cells". This is our observation (both, in stainings and in live imaging -- [Video 4](#media4){ref-type="other"}). Anyway, after revising the literature, this staining has been seen before in another work ([Figure 4H](#fig4){ref-type="fig"} in Denholm et al., 2005 Development 132:2389), but not explicitly mention in the text or the figure.

*Also, given that the core of microvilli consists of actin filaments, I don\'t understand why microvilli are not visible in the* foscrb *and Y10F animals ([Figure 2G and H](#fig2){ref-type="fig"}). (Under appropriate conditions, ena might also be visible in the microvilli, but previous reports suggest it is visible primarily if ena is over expressed).*

Indeed, the confocal was adjusted in a way that only the signal from the cable is visible. The filopodia are there, but to see them, the gain and power of the laser have to be enhanced and the cable will appear as a blob completely out of range.

*In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", the authors state: \"The formation of the actomyosin cable at the LE depends on the asymmetric accumulation of the adhesion protein Echinoid (Ed) in the DME cells (Laplante and Nilson, 2011; Lin et al., 2007)".As written only readers familiar with the referenced work will realize that the asymmetry of Ed protein in the DME cells is not normal and that it is asymmetry in the distribution of Ed between the epidermis and the amnioserosa that is relevant. They also state that \"Removal of Ed from the LE is evident in* foscrb *and* foscrb~Y10F~ *embryos ([Figure 2J, K](#fig2){ref-type="fig"}, arrowheads mark Ed absence at the LE)\", but Ed is also not present at the leading edge of the DME cells in Y10A animals.*

We re-wrote the paragraph to make clear that the distribution of Ed in the *foscrb* embryos is like the one reported for wild type embryos. Also, we point out that the phenotype in the *foscrb~Y10A~* embryos is that the overall level of Ed in the DME is reduced, and not that Ed is absent from the LE (subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable in the DME cells").

*Moreover, the data presented in [Figure 2O](#fig2){ref-type="fig"} is not at all convincing. Baz is present at the leading edge of only one Y10A cell and it is possible that the dark line shown is background, like the line just above the arrow, deeper in the amnioserosa.*

This is addressed also in your point \#4 above, and besides the line profile, in the [Figure 2--figure supplement 3B, B](#fig2s3){ref-type="fig"}' you may also see that both dark lines localise in the same plane as the phosphotyrosine staining, evidencing that it is not background.

*In the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable", sixth paragraph: Gorfinkiel and Arias 2007 show very convincingly that* D*E-cad initially localizes to the LE, but later during closure is lost from the leading edge (see Gorfinkiel and Arias [Figure 1](#fig1){ref-type="fig"}). The authors need to verify that their observations on the fosmid rescue embryos are consistent with the literature and consider how clearing the leading edge of* D*E-cad is consistent with the mechanisms they propose here. Moreover, the quality of the* D*E-cad stained images lacks contrast (compare Gorfinkial and Arias, Figure Aiii and Biii to this manuscripts [Figure 2P, Q and R](#fig2){ref-type="fig"}). Better stained preparations might give better insight into* D*E-cad distributions in the Y10A animals.*

This is in part the same as the comment \#5; see answer above. For the [Figure 2P, Q and R](#fig2){ref-type="fig"}, we acquired new images, which are now shown in [Figure 2K, L](#fig2){ref-type="fig"} and [Figure 2--figure supplement 5F](#fig2s5){ref-type="fig"}.

*In the subsection "The FBM of Crb is essential for the morphogenesis of the AS", second paragraph: The authors claim that there are discontinuities in* D*E-cad localization in Y10A animals which appears to be the case, although if the structure of the AS is considerably different than wildtype. How do the authors know that the* D*E-cad junctions haven\'t simply gone out of the plane of section? Moreover, the authors cite large aggregates of* D*E-Cad-GFP in the cytoplasm of the Y10A cells, but there seem to be a few such aggregates even in* foscrb *animals and large numbers of such aggregates in the Y10F animals (i.e., numbers comparable to those seen in the Y10A cells, see 3A\' and 3B\', respectively).*

To resolve this issue, we generated recombinants of *D*E-cad::mTomato with the different *foscrb* variants. This led us to analyse in a better signal-to-noise ratio condition the localisation of *D*E-cad ([Figure 3](#fig3){ref-type="fig"} and [Video 4](#media4){ref-type="other"}). The previous images, using the *D*E-cad::GFP allele, were misleading some reviewers, because the auto-fluorescence of the yolk was taken as intracellular aggregates of *D*E-cad::GFP.

In the image provided in the first version of our manuscript we were able to tell them apart from the *D*E-cad intracellular aggregates using the original data because the yolk granules localise deep in the embryo. Now, employing the *D*E-cad::mTomato allele it is possible to show the maximal projection without so much interference of the yolk as its auto-fluorescence is lower in the emission spectrum of mTomato (around 560-600 nm). Nevertheless, [Video 5](#media5){ref-type="other"} still shows the analyses with the *D*E-cad::GFP allele, but a note was added to the Video legend.

*In the subsection "The FBM of Crb is essential for the morphogenesis of the AS", fifth paragraph, the authors state: \"Apoliner expression in the AS of* foscrb *and* foscrb~Y10F~ *embryos ([Video 9](#media9){ref-type="other"}) revealed some apoptotic cells at the posterior canthus at the end of GB retraction ([Figure 4A, B](#fig4){ref-type="fig"}, arrows). In* foscrb~Y10A~ *embryos of a similar age, some detached cells ([Figure 4C](#fig4){ref-type="fig"}, arrowheads) as well as those at the posterior edge of the remaining AS ([Figure 4C](#fig4){ref-type="fig"}, arrow) appear as apoptotic cells.\" First, the authors miss a key paper on apoptosis in the amnioserosa (Shen et al. 2013 PLoS ONE 8:e60180), which presents data in form that is much easier to interpret (see Shen et al. [Figure 5](#fig5){ref-type="fig"}).*

In our hands, and with the GAL4 driver employed, the GFP signal from Apoliner is not visible in the nucleus, but appears to be degraded (as reported in Kolahgar et al., 2011 Development 138:3021 -- which is the same group that generated the Apoliner marker).

*To me, the data presented here suggest that despite substantial differences in AS morphology, that the level of apoptosis in Y10A animals is about the same as in* foscrb *and Y10F embryos (there may be some additional apoptosis at lesions in the AS).*

If you see the current [Video 6](#media6){ref-type="other"} when it shows the time 210 min, and you take into account that those embryos were collected, incubated and imaged at the same time, you can observe that at 10-10.5 h after egg collection, the apoptosis levels in the AS is very different between *foscrb* and *foscrb~Y10A~* embryos. Therefore, we conclude that apoptosis is premature in the *foscrb~Y10A~* embryos when compared with time-matched controls (*foscrb* embryos).

*The authors go on to write \"At the end of DC, the internalised AS cells are localised in a central rod-like structure in* foscrb *and* foscrb~Y10F~ *embryos and subsequently die by apoptosis ([Figure 4D, E](#fig4){ref-type="fig"}) \[as has been reported for wild type embryos (Reed et al., 2004)\], while in* foscrb~Y10A~ *embryos of similar age, the remaining AS cells have completely disaggregated ([Figure 4F](#fig4){ref-type="fig"}).\" What do they authors mean by \"a similar age\"?*

We removed the term "similar age" from all the text. Instead, the reader is referred to the Material and methods for details about embryo staging (Results, second paragraph and Materials and methods, second paragraph). We now use "incubated for the same period of time" or "at this time point".

*To me this is completely consistent with the interpretation that morphogenesis is delayed and the programed cell death of the AS occurs \"normally\" in the animals with all three* foscrb *variants.*

As discussed in the comment to your point \#7, the delayed morphogenesis in the *foscrb~Y10A~* embryos seems very unlikely.

*The authors go on to state \"To summarise, the AS in* foscrb~Y10A~ *embryos breaks apart and undergoes premature apoptosis\". I agree that the AS breaks apart, but it is not clear from the data as described that the apoptosis is \"premature\".*

We think that with the details added to the text, the movies, the figure legends and the Materials and methods, these questions are answered.

*They next write \"suggesting that an intact FBM is required for maintaining the elasticity of the AS\". There is nothing in this paper that evaluates the \"elasticity\" of the AS. Again, they need to know that* crb *is folding properly to draw conclusions about a defective FBM (vs. a key role for crb) and they can at best replace \"elasticity\" with \"integrity\".*

We have addressed this issue (please see the subsection "The FBM of Crb is essential for the integrity of the AS", first paragraph).

Reviewer 4:

*We know from previous work that the Crumbs FERM domain-binding motif (FBM) directly interacts with the FERM-domain of Yurt (Yrt) and Expanded (Ex) and recruits Moesin to the apical membrane. And we know that mutation of this domain has no effect on the many other tissues where Crumbs has a role, but has lethal phenotype in the embryo, which this study shows to be due to an overactive actomyosin network. The live-imaging of Cadherins using* D*E-cad::GFP knock-in allele in a* crb *null background with formed introduced variants of crumbs is well-executed, systematic and key part of the study from which the conclusions are derived. The authors cleanly demonstrate a Yrt independent role and then show that* foscrb~Y10A~*show defects in the establishment of the actomyosin apparatus cells in a situation where components of the Zonula Adherens are disturb or missing. Next the authors go on to show that the FBM of Crb is an important regulator of cytoskeletal activity and cell-cell adhesion of the amnioserosa and required for its proper morphogenesis. The next set of experiments are the \'meat\' of the paper and they comprehensively address the role of Crumbs FBM in actomyosin dynamics and show that the FBM of Crb regulates actomyosin dynamics in the amnioserosa during dorsal closure by down-regulating the Rho1 pathway. Finally the authors show that the dorsal-closure phenotype of Crb~Y10A~ embryos also due to reduced adhesion. The authors have carefully dissected out Crumb function through the FBM. As they point out we do not yet know if the actomyosin phenotype and the reduced adhesion ones are linked or not. The phenotypes could result from defects in amnioserosa differentiation or in its attachment to the basal lamina. The authors raise this point themselves and have \'data not shown\' to negate such conclusions. It will be good to see this data.*

Data was included as [Figure 4--figure supplement 1](#fig1){ref-type="fig"} and [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}.

*While the work convincingly demonstrates a novel function of the FBM in cytoskeleton dynamics and also show that Crb regulation of amnioserosa morphogenesis involves* D*Moesin, Rho- GTPases, class-I Pak, and the SCAR-Arp2/3 complex, two questions remain. How does this regulation take place (three ways are suggested) and why other epithelia which require Crumbs does not seem to require this domain (while requiring the downstream partners). The key question then is whether the role of the FBM show is a peculiarity that details out an aspect of Crumbs or if it is telling us something broader about its role in epithelial morphogenesis. It will be good to see a discussion on this.*

In fact, this is an interesting question, the solution of which goes beyond the scope of this work. We raised this question at the end of the Discussion, but possible scenarios appeared too speculative and therefore we did not elaborate on this point.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Reviewer 2:

*\[...\] I particularly like [Figure 7--figure supplement 1](#fig7s1){ref-type="fig"} more than new [Figure 7. I](#fig7){ref-type="fig"} find the genotypes are easier to follow and think the subtleties of the DC defects are important. The addition of error bars is a good idea but in this case I would also add statistical significance of the differences observed.*

We analysed the statistical significance of the data presented in the [Figure 7--figure supplement 1](#fig7s1){ref-type="fig"} by a one-way-ANOVA followed by a Dunnet's multiple comparisons test. Because this analysis requires data that is continuously variable, the percentages were first converted to arcsin values and then analysed with GraphPad Prism. This is also described in the Material and methods, subsection "Statistical analyses".

We consider that the addition of more symbols, arrows or asterisks to the graph in the [Figure 7--figure supplement 1](#fig7s1){ref-type="fig"} will make it hard to read and understand, so we present the results of such analyses as a summary in the form of a Table ([Table 1](#tbl1){ref-type="table"}), and added a note to the legend of the [Figure 7--figure supplement 1](#fig7s1){ref-type="fig"}.

*I suggest Figure 5--figure supplement 2 goes to the main text: it\'s a very important piece of data and captures very nicely the behaviour of actomyosin foci.*

Done, It now corresponds to [Figure 5E](#fig5){ref-type="fig"}.

Reviewer 3:

*\[...\] I still have 6 concerns that should be corrected before publication. The authors assert that Baz is retained at the leading edge of Y10A embryos. The micrograph they present in 2J is simply not compelling and the rebuttal they provide is simply not convincing. If Baz is preserved at the leading edge in Y10A embryos surely a micrograph that provides more compelling evidence should be easy to obtain? Compare their localization of Baz in wild type to that presented by Laplante and Nilson, 2011, which they cite.*

It appears that our text was not completely clear. There are two effects on Baz in *foscrb~Y10A~* embryos: i) we wrote that "*foscrb~Y10A~* embryos preserve Baz at the LE of those cells that fail to elongate ([Figure 2J](#fig2){ref-type="fig"}, arrow)". So there is no general loss of Baz at the LE, as written by the reviewer; ii) there is a general reduction of Baz in the junctions of *foscrb~Y10A~* embryos, as shown in [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"} and now written in the fourth paragraph of the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable in the DME cells" and added to [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"} legend.

The difference between our staining and the one presented in Laplante and Nilson, 2011 may be due to many different factors (concentrations, secondary antibodies, incubation times, image processing, etc.). We repeated the stainings, but we obtained the same results shown in the referred [Figure 2J](#fig2){ref-type="fig"} and [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"} (see [Author response image 3](#fig3){ref-type="fig"}). The higher background in our stainings may be due to the fact that the antibody in Laplante and Nilson 2011 is a rat antibody (from Wodarz, A., Ramrath, A., Kuchinke, U., and Knust, E. (1999). Nature 402, 544; but Laplante and Nilson do not specify whether they used the rat anti-Baz C-term or the rat anti-Baz N-term) and we used a rabbit one generated against Baz-GST-N-Term containing aa 1-297 of Bazooka protein from *Drosophila*. We also avoided to increase the contrast, which we think was done in [Figure 4A](#fig4){ref-type="fig"}' and B' of Laplante and Nilson, 2011.

In [Author response image 3](#fig11){ref-type="fig"}, there are 3 different *foscrb* and *foscrb~Y10A~* embryos, respectively, stained for Bazooka and phospho-tyrosine (associated with the ZA). The arrowheads in the control embryos mark where Baz is absent from the LE (as has been shown in wild type embryos, Laplante and Nilson 2011). The arrows in the *foscrb~Y10A~* embryos show that most cells that do not elongate in the LE of *foscrb~Y10A~* embryos preserve the localisation of Baz at the LE, as we report in the [Figure 2J](#fig2){ref-type="fig"} and [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"}.10.7554/eLife.07398.047Author response image 2.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.047](10.7554/eLife.07398.047)10.7554/eLife.07398.048Author response image 3.**DOI:** [http://dx.doi.org/10.7554/eLife.07398.048](10.7554/eLife.07398.048)

These results are identical to the ones presented in the manuscript in the [Figure 2J](#fig2){ref-type="fig"} and [Figure 2--figure supplement 3](#fig2s3){ref-type="fig"}, thus we do not see the necessity to modify those figures.

*[Figure 2M and N](#fig2){ref-type="fig"} show schematics to help the reader figure out what the main features of the Y10A phenotypes are. There is little or no evidence for the presence of a conventional myosin in filopodia. Interestingly, although the Sas data show filopodia, neither the actin nor the myosin panels show filopodia very well (there seem to be some filopodia in the actin panel E). The schematic that shows \"actomyosin\" should be removed. Actin might be shown in filopodia the actomyosin cable, myosin should be shown only in the actomyosin cable.*

Corrected as suggested by Reviewer 1.

*Gorfinkiel and Martinez-Arias (2007) showed that while Cadherin is initially localized to the leading edge of the DME cells, that it is cleared with time. In my first review, I was afraid that the phenotype shown for loss of cadherin in Y10A animals was due to the normal clearing of cadherin from the leading edge later in closure. The authors provide a convincing rebuttal that they are comparing early stage* foscrb *animals to early stage Y10A animals. They should simply add a sentence to the revised manuscript to indicate that they know that cadherin is cleared at later stages and that this comparison is between different genotypes during early closure stages. The readers need to know this as much as do the reviewers.*

This has been corrected (please see the subsection "The FBM of Crb regulates filopodia formation and organisation of the supracellular actomyosin cable in the DME cells", sixth paragraph).

While pulsing or oscillating amnioserosa cells characterize dorsal closure in wild type embryos and are very interesting, it is not clear to me that oscillations \"are required\" for closure. Thus, oscillations can be suppressed and closure still occurs. The sentence that begins "Besides elongation of the DME cells and integrity of the AS, DC requires pulsed contractions of the AS cells..." should be revised.

We revised the sentence to read "perturbing actomyosin dynamics of the AS cells interferes with normal DC" and also added a reference about the effects of perturbed actomyosin dynamics on the DC: Fischer et al. (2014) PLoS ONE 9, e95695.

*[Figure 6G](#fig6){ref-type="fig"} is referenced as a model for how the FDB of Crb might regulate cytoskeletal function. I am puzzled by some of the details. In particular, the model has Rok and* D*Pak as positive regulators of MLCK. My understanding is that MLCK, Rok and* D*Pak all phosphorylate sqh directly, so arrows from Rok and Pak to MLCK and not to sqh are at best misleading and more likely simply wrong (unless there are data in the literature that I simply don\'t know about). Second, Rok has an inhibitory connection to flapwing. Is that really the case? Does Rok phosphorylate Flapwing to inhibit its phosphatase activity or otherwise bind to Flapwing to sequester its activity?*

Corrected, now the arrows indicate that MLCK, Rok and *D*Pak all phosphorylate Sqh directly. We also added the *Drosophila* myosin-binding-subunit (*D*MBS) to the scheme, which is phosphorylated by Rok, resulting in the inhibition of the phosphatase activity. We also added the definitions of the abbreviations to the figure legend.

[^1]: One-way-ANOVA analysis followed by a Dunnet's multiple comparisons test between the indicated categories of the different genotypes. Statistical significant difference indicated as follows: **ns** p\>0.05; **\***p≤0.05; **\*\***p≤0.01; **\*\*\***p≤0.001; **\*\*\*\***p≤0.0001.

[^2]: Invitrogen, Molecular Probes (Eugene, Oregon, USA); DSHB - Developmental Studies Hybridoma Bank (Iowa city, Iowa, USA).
